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Abstract
Nanoparticles have potential biomedical applications because of their special physi-
cal properties. Multi-scale nanoparticles contrast agents are those particles that provide
contrast in different scale imaging modalities. Such particles are of great interest for
monitoring anti-cancer drug delivery, allowing investigations of whole body drug dis-
tribution as well as that at the microscopic level. Magnetic nanoparticles in particular
have been used as contrast agents in MRI and optical techniques such as confocal
microscopy and two photon fluorescence (TPF) microscopy to achieve multiple scale
imaging. However, confocal microscopy has a limited optical penetration in biological
tissue. Moreover, both techniques, confocal microscopy and TPF microscopy, require
labelling of the biological tissue which alters the particle distribution and complicates
the biological system under-investigation.
Coherent Raman scattering (CRS) imaging techniques are label-free with chemical
contrast and relatively large optical penetration. To the best of the authors knowledge,
only one study was carried out to image magnetic particles with such an imaging system
using a four wave mixing (FWM) process. However, micro-sized particles were used and
such size is not typical for drug delivery applications.
The aim of this thesis is to develop techniques to combine the two scales imaging
modalities, MRI and CRS in order to image the well-established MRI contrast agents,
iron oxide and gadolinium oxide nanoparticles in a biological context. Moreover, the
thesis examines the label-free ability of MRI and CRS to determine tumour boundaries
through ex-vivo imaging of a mouse brain tumour.
In MRI, it was found that the optimal contrast between healthy tissue and tumour
for formalin fixed mouse brain is achieved when a spin echo (SE) sequence with TE/TR
= 3000/110 ms is applied. The tumour edges were extracted at high resolution (0.125 ×
0.125 × 0.150 mm3) which allows measuring the tumour volume in a clinically available
1.5 T MRI scanner with such resolution for the first time. The high resolution label-
free volumetry data was used as a gold standard to estimate experimental error in
conventional histology tumour volume measurements and it was found that 20 % average
error results from tumour shape irregularity. A mosaic CARS image of a tumour slice
was produced with a novel technique that compensates for phase curvature.
The magnetic nanparticles were synthesised with homogeneous precipitation and
hydrothermal methods and a tuneable mono-disperse sizes were achieved. It was found
that the Er doped gadolinium oxide nanoparticles pose a strong upconversion when
excited with a 816 nm laser. Doped gadolinium oxide nanoparticles were imaged in
CRS system with four wave mixing (FWM) and UC photoluminescence in a biological
model. Also, Iron oxide nanoparticles were imaged using FWM and two photon photo-
thermal lensing (TPPL).
It can be concluded that MRI and CRS are capable of determining tumour edges
in a label-free manner. Moreover, CRS system can be utilised to image nanoparticles
contrast agents in a biological tissue with a number of potential optical techniques.
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Chapter 1. Introduction
Chapter 1
Introduction
Multi-scale nanoparticles contrast agents are nanoparticles that provide contrast in both
large scale and microscopic imaging modalities. The development of such particles would
lead to better understanding of the mechanism of uptake of anti-cancer drugs at the
whole body and the cellular level. Cancer drug resistance in tumours is considered as
one of the major obstacles toward an effective treatment due to the complicated tumour
microenvironment that results in poor drug penetration and insufficient uniform drug
distribution [1,2]. Tumour cells form pockets that resist chemotherapy and survival of a
single cancer cell might reinitiate a new tumour. Nanomedicine has been used widely not
only to overcome this obstacle, but also to reduce the side effects of drugs via targeted
delivery where the medicine only kills tumour cells [3,4]. Magnetic nanoparticles in par-
ticular have received remarkable research attention for their targeted therapy potential
provided either by magnetic targeting or with specific targeting ligands [5–8]. However,
a considerable amount of effort is still required to engineer enhanced nano-therputic
nanostrucures and multi-scale imaging techniques are required to assess efficiency of
targeting and curing [9]. The imaging technique, on one hand, should comprehensively
cover the overall large-scale drug distribution over the whole body volume to inspect
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targeting a specific organs or tissue. On the other hand, it should provide microscopic
details about drug distribution in tumours to allow investigation of its efficiency to
overcome the drug resistance which occurs in the tumour microenvironment. Unfortu-
nately, with the current available technologies these imaging scale specifications can not
be provided by a single imaging modality. Magnetic resonance imaging (MRI) and X-
ray computational tomography (CT) are capable of large scale imaging but the spatial
resolution of both modalities is not at the level of probing the microscopic cellular de-
tails [10, 11]. Optical microscopy can image the microscopic details of biological tissue,
but its imaging penetration and field of view are limited to several hundred micrometers
depending on the specific utilised technique [12]. Accordingly, a considerable number of
previous studies suggested dual-modality imaging combining two different scale imag-
ing techniques with nano-contrast agents to achieve the comprehensive monitoring of
drug distribution [13]. Regarding whole body imaging, MRI offers enhanced contrast
when imaging soft tissue and greater contrast of magnetic nanoparticles in comparison
to CT [14]. For this reason this thesis will be limited to those multi-modal imaging
studies in which MRI was used for the large scale imaging. Several studies combined
MRI with confocal microscopy to image fluorescent magnetic nanoparticles in biologi-
cal tissues [15–21]. However, confocal microscopy has a limited optical penetration in
scattering tissue and suffers from photobleaching since a single-photon fluorescence sig-
nal is generated above and below the focal plane [22]. Instead of confocal microscopy,
a number of other previous studies utilised two-photon fluorescent (TPF) microscopy
that benefits from nonlinear excitation to increase the optical penetration and to re-
duce photobleaching [23–26]. Nevertheless, both confocal and two-photon microscopies
require labelling the biological tissue which complicates investigating the distribution
of multi-scale nanoparticles at the cellular level. Raman microscopy provides label-free
contrast of the biological tissue via molecular vibrational imaging, but it requires a
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very long acquisition time (hours) [27]. Coherent Raman scattering (CRS) techniques
provide label-free microscopy of biological tissues with chemical contrast, great optical
penetration, and reasonable imaging time [28, 29]. To the best of the author’s knowl-
edge, there is only one previous study in which magnetic particles were imaged under a
CRS system [30], however micro-particles were used which is considered as a limitation
since such particle size is not suitable for tumour uptake.
The aim of this thesis is to investigate possible methods of using magnetic nanoparti-
cles as multi-scale contrast agents in both MRI and CRS. The motivation as mentioned
above is to propose these particles as delivery and tracking agents for anti-cancer drugs
in the label-free imaging modalities. The thesis is structured in six chapters in addition
to the current chapter. In chapter two, the theoretical background techniques required
for spectroscopy, imaging, characterisation, and synthesis of the particles will be pre-
sented, while chapter three will cover the experimental specifications of these techniques.
In chapter four, the label-free ability of MRI and CRS to determine tumour edges will
be investigated. This will be accomplished by imaging mouse brain tumours with MRI
and CARS in a collaborative study with the London School of Pharmacy to measure
tumour volume as a response to different cancer medicines. Also, a technique will be
developed to compare images of the two different scale imaging modalities. In Chap-
ter five, the magnetic particles material, size, morphology, crystalline structure, optical
and magnetic properties will be characterised. Chapter six demonstrates the optical
contrast that can be obtained from particles in model biological samples. Finally, the
conclusion and future work will be presented in chapter 7.
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Chapter 2
Background Theory
2.1 Introduction
This thesis describes the application of multiple imaging modalities to characterise or
image biological tissues, or nanoparticles within a biological model. The aim as stated in
the introduction is to propose practical methods for imaging nanoparticles both in MRI
and non-linear optical microscopies. This Chapter presents the theoretical background
of these imaging techniques.
2.2 MRI
2.2.1 Introduction
In 1946 Felix Bloch and Edward Purcell discovered the magnetic resonance phenomenon
independently. Both were awarded the Nobel Prize in 1952 for this. However, it was not
until 1975 that Richard Emst proposed the frequency and phase coding method which
takes advantage of the phenomenon for imaging.
Since then, magnetic resonance imaging (MRI) has been widely utilised for medical
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diagnosis. It is a non-invasive imaging technique, based on the magnetic properties of
nuclei. When a biological tissue is placed in a strong magnetic field the nuclei align
parallel or anti-parallel to it. Applying an external radio source at an appropriate
frequency the nuclei resonate and absorb energy. Accordingly, more nuclei align anti-
parallel to the magnetic field. On switching off the radio source the biological tissue
re-emits the energy as radio waves as a relaxation process to return to equilibrium. A
3D image of the biological tissue can be reconstructed from this signal.
2.2.2 Atomic structure
The atom consists of a nucleus surrounded by an electronic cloud. The nucleus contains
positively charged nucleons (protons) and uncharged nucleons (neutrons). The atomic
electrons occupy a set of energy levels. The transition of an electron between two energy
levels (orbits) is caused by a loss in its energy via photonic emission, or an energy gain
via absorbing a photon. For such a process to occur, the photonic energy should match
the energy difference between the energy levels. Optical properties of atoms will be
considered in more detail in Section(2.3). The physics of the atom on the microscopic
scale is explained by quantum mechanics. However, it is sufficient for most of the
topics of this chapter to apply a classical mechanical approach, although the quantum
mechanical approach will be applied when it is necessary. According to a classical
picture, electrons orbit the nucleus and spin on their own axes, while the nucleus also
spins on its axis. Quantum mechanically, the electron, the proton and the neutron have
spin of 1/2; the nuclear angular momentum is the vector sum of the angular momentum
of the individual nucleon - spins plus orbital angular momentum within the nucleus.
(In MRI of hydrogen, where the nucleus is a single proton, the nuclear spin is 1/2, with
a component +1/2 or -1/2 in the direction of the applied magnetic field; the + and -
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signs indicate spin up or spin down, the only two possible spin energy states.)
As stated by the Biot-Savart law, a moving charge generates a magnetic field. If
this charge moves in a loop, there will be a magnetic moment associated with it. An
orbiting charged particle can be considered as a current loop, with an associated mag-
netic moment. The spin of a charged particle on its axis can also be considered as a
current loop, so the proton has an intrinsic magnetic moment associated with its spin
(as does the neutron, although a classical model does not provide a simple explanation
for this). The nucleus as a whole has a magnetic moment associated with its overall
angular momentum.
2.2.3 Active MRI nuclei
As mentioned in the previous section, the spin of the nucleus results from the spin of its
nucleons. The nucleons are organised in pairs in such a way that a nucleus with even
mass number A (number of nucleons) and even atomic number Z (number of protons)
exhibits no net spin. If A is even and Z is odd, the nucleus has integer spin values (1,
2, 3.). If A is odd, the nucleus has half-integer spin values (1/2, 3/2, 5/2.).
According to the above, not all nuclei are useful in the context of MRI, since non-zero
nuclear spin is required to give the necessary non-zero magnetic moment. Examples of
MRI active nuclei are 1H (spin 1/2), 13C (spin 1/2), 15N (spin 1/2), 17O (spin 5/2) and
19F (spin 1/2). Among those nuclei, 1H exists in abundance in biological tissue. This is
because more than 70% of the human body consists of water (H2O). Also, fat molecules,
which exist in about 20% of the human body, have hydrogen atoms in their molecular
structure.
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2.2.4 Alignment
As discussed in the previous section, active MRI nuclei have a magnetic moment. The
nuclei are orientated randomly in the absence of magnetic fields (Fig.2.1).
Figure 2.1: Orientation of nuclear spins in the absence of a magnetic field.
However, when they are placed in a strong magnetic field, the nuclear spins align
either parallel or anti-parallel to the applied field (Fig.2.2).
B0B0
Before After
Figure 2.2: Alignment of nuclear spins in an external field before and after an RF pulse.
This corresponds to the only available energy states: spin up and down. (Note:
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here we consider only the case of spin -1/2 nuclei, for simplicity.) This is a situation
that can only be explained by quantum mechanics; classically one would expect that
most of the nuclei would align with the magnetic field, and would not expect the anti-
parallel alignment. However, classical physics provides an equivalent analysis: If the
magnetic moment of a nucleus is directed at any non-zero angle with respect to an
applied magnetic field, the magnetic moment moves around the direction of the magnetic
field in a motion known as precession (Fig.2.3).
B0
Figure 2.3: Precession of a nuclear spin.
The frequency at which the precession occurs depends on the nature of the nu-
cleus and the strength of the applied magnetic field. This relationship is described by
Equation(2.1)
ω0 = γB0 (2.1)
where ω0 is the precession (angular) frequency, also known as the Larmor frequency,
γ is the gyro-magnetic ratio, which is determined by the type of nucleus and B0 is the
strength of the magnetic field. It might be relevant to mention that the hydrogen nucleus
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(the proton) has a relatively high γ value. This results in greater sensitivity (higher
signal) when using hydrogen nuclei in an imaging experiment, compared to nuclei with
lower values of γ.
The nuclei that are aligned anti-parallel to the direction of the external magnetic
field are in a higher energy state. In thermal equilibrium the number of nuclei with
higher energy (anti-parallel alignment) is less than the number of parallel-aligned nuclei
(lower energy) according to the Boltzmann distribution law.
Nap
Np
= e−∆E/kT (2.2)
where Nap is the number of antiparallel-aligned nuclei per unit volume, Np is the num-
ber of parallel-aligned nuclei per unit volume, ∆E is the energy difference, k is the
Boltzmann constant and T is the temperature in Kelvin. The energy difference can be
calculated from Equation(2.3).
∆E = h¯ω0 = h¯γB0 (2.3)
Where h¯ = h
2pi
is the reduced Planck’s constant.
2.2.5 Resonance and relaxation
In order to change the populations of the energy states, an external source of radio
frequency (RF) waves at the Larmor frequency is required. Some of the nuclei will
resonate, absorbing energy to jump to the higher energy state (anti-parallel aligned).
This causes an increase in the number of nuclei in the higher energy state compared
to the number in the lower energy state. In the case of a 1.5 T clinical scanner used
to image protons (hydrogen nuclei), the difference in populations is about 4 protons
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in every million. When the RF excitation is switched off, the protons return to their
thermal equilibrium distribution, emitting RF energy at the Larmor frequency.
In the classical interpretation, on the macroscopic scale the applied magnetic field
B0 induces a magnetisation in the sample which can be represented by the net magnetic
vector (NMV). The NMV is disturbed from its equilibrium orientation when an RF
pulse is applied at the Larmor frequency ω0, and starts to precess about the direction
of B0 and at the Larmor frequency. One can consider two frames of motion. The first
is the Laboratory frame, in which the NMV is seen to precess at ω0. The second is
the rotating frame, in which the the observer rotates at ω0 and the precession of the
NMV is frozen and the observed effect of the RF pulse is to increase the flip angle α
(Figure.2.4). If a 90◦ pulse is applied, the flip angle increases from zero to 90◦ during
the duration of the pulse. After the RF pulse, the NMV returns to its initial status
pointing parallel to B0.
The direction of the applied field B0 is conventionally known as the longitudinal
direction and lies perpendicular to the transverse plane (Fig.2.4).
20
Chapter 2. Background Theory
B0
Longtudinal Plane 
Transverse Plane
NMV
∝
Figure 2.4: Illustration of the NMV, the longitudinal direction, the transverse plane,
the flip angle and the direction of the static magnetic field B0.
Hence the effect of a 90 pulse is to tip the NMV from the longitudinal direction into
the transverse plane. It is important to emphasize that the transverse and longitudinal
components of the NMV have different relaxation times. This results from the fact that
the relaxation processes are different in each case. The recovery of the longitudinal
component arises from nuclei in the higher-energy state (spin down) losing energy and
returning to the lower-energy state (spin up). This phenomenon depends on interaction
with the environment, known as the lattice. For this reason the associated time constant
is known as the spin-lattice relaxation time given the symbol T1. In contrast, the
decay of the transverse component results from the dephasing of the nuclear spins. This
phenomenon depends on magnetic interaction between the spins. Consequently, the
associated time constant is called the spin-spin relaxation time given the symbol T2.
Both relaxations are exponential with time (Fig.2.5.).
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Figure 2.5: Longitudinal component recovery and transverse component decay curves
(The figure was taken from reference [10]).
After a 90◦ pulse, the longitudinal component (Mz) recovers to 63% of its maximum
in a time T1. The decay in the transverse component (Mxy) reaches 37% of its maximum
after a time T2. These two time constants are intrinsic properties of the tissue being
imaged. So, one cannot change their values by varying the settings of the MRI scanner.
However, having knowledge about their estimated values allows the investigator to select
the optimum imaging parameters.
2.2.6 Signal detection
After an RF excitation, in the Laboratory frame the NMV rotates (precesses) at the
Larmor frequency ω0. According to Faraday’s law of induction, an electrical signal will
be generated in a coil of wire with its axis in the transverse plane. (The magnetic field
associated with the NMV is very small compared to the applied field: about 1 µT for
the whole human body in a 1.5 T scanner.) The amplitude of the RF signal detected
by such a coil is determined by the transverse magnetisation Mxy and hence varies as
sin(α) (Figure 2.4). This implies that the optimum flip angle for detecting the NMV is
90◦.
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The magnitude of the flip angle α depends on the amplitude and time duration of
the RF pulse. This can be expressed mathematically by
α = γB1tp (2.4)
where α is the flip angle, B1 is the amplitude of the magnetic component of the RF
wave, and tp is the duration of the pulse.
If a 90◦ pulse is applied, the NMV is tipped entirely into the transverse plane (Fig-
ure.2.6). The signal recorded after a 90◦ pulse will decay in a manner illustrated in
Figure.2.7.
y′
x′
z
Figure 2.6: The NMV orientation in the rotating frame just after a 90◦ pulse
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Figure 2.7: Free induction decay (FID)(The figure was taken from reference [10])
This type of signal is known as a free induction decay (FID). However, in imaging
the signal received is of a different form; an ”echo” is created using sequences such as
spin echo and gradient echo which will be explained in the following section.
2.2.7 Imaging sequences
The two commonly used sequences in MRI are spin echo (SE) and gradient echo (GE).
In the SE sequence (Fig.2.8), the initial 90◦ RF pulse is followed by a 180◦ pulse.
Dephasing of spins that have accumulated during the period between the two RF pulses
(Fig.2.8, c) is changed in sign by the 180◦ pulse (Fig.2.8, d). Hence phase changes over
the following period (Fig.2.8, e) act to rephase the signal. After a time equal to the
time between the 90◦ and 180◦ pulses, the spins will be in phase. The moment of spins
being in phase (Fig.2.8, f) is known as the echo and the time from the 90◦ pulse to the
echo is the echo time (TE). This process is repeated to obtain a complete image; the
time between successive 90◦ pulses is known as the repetition time (TR).
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Figure 2.8: Spin-echo pulse sequence( reference [10] )
When spin-echo sequence is utilised, the signal intensity is given by Equation(2.5)
[10]
ISE = c
[
1− 2e−(TR−TE/2T1 ) + e−TRT1
]
e
−TE
T2 (2.5)
Where, c is a constant related to the MRI hardware properties, and, TE and TR
are the echo and repetition times respectively. In Equation 2.5, T1 and T2 are intrinsic
properties of the sample, whereas, TE and TR, are controlled imaging parameters. The
sequence is T1 weighted when these two parameters are chosen to highlight the variation
in T1 more than T2 and vice versa. This actually requires previous knowledge about T1
and T2 of the sample, or, instead, one can rely on the fact that T2 is always shorter than
T1.
In the GE sequence (Fig.2.9) an RF excitation pulse of 90◦ or less is followed by
a negative gradient of magnetic field over the workspace. This produces significant
additional dephasing of the nuclear spins and hence loss of the MR signal. However,
application of a positive magnetic-field gradient then rephases the spins, producing an
echo in a similar way to the SE sequence, described above. Again, the time from the
90◦ pulse to the echo is the echo time (TE), and the process is repeated to obtain a
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complete image; the time between successive 90◦ pulses is known as the repetition time
(TR).
Si
gn
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Figure 2.9: Gradient Echo pulse sequence(reference [10] )
The signal intensity in a gradient echo sequence obeys the following equation
ISE = c
[
1− e−TRT1
]
e
−TE
T2 (2.6)
where, again, c is a constant associated to the MRI hardware, and, TE and TR are
the echo and repetition times respectively.
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2.2.8 The Bloch equations
In 1946, after discovering the phenomenon of magnetic resonance, a set of equations that
describe the variation in the magnetisation components were derived by Felix Bloch [31].
From a classical mechanics paradigm, they describe the signal detected by the MRI
receiver. Starting with
dM
dt
= γM×B = γ

(MxBz −MzBy)i
+(MzBx −MxBz)j
+(MxBy −MyBx)k
 (2.7)
Here M is the magnetisation induced in the bulk material, B the applied external
magnetic field and γ is the gyromagnetic ratio. The magnetic field B is the vector
summation of the static external magnetic field B0 and the oscillating magnetic field
produced by the RF where
Bx = B1 cosωt,By = B1 sinωt,Bz = B0 (2.8)
In a typical situation the frequency of the RF pulse will be chosen to be in resonance
with the precession ( ω = ω0 = γB0 ). Observing that the relaxation processes in the
z direction and the xy-plane occur at different rates, Bloch added relaxation terms to
the component form of Equation(2.7) to obtain
dMx
dt
= γ(MyB0 +MzB1 sinωt)− Mx
T2
(2.9)
dMy
dt
= γ(MxB1 cosωt+MxB0)− My
T2
(2.10)
27
Chapter 2. Background Theory
dMz
dt
= γ(MxB1 sinωt+MyB1 cosωt)− Mz −M0
T1
(2.11)
It can be seen that, when the RF pulse is switched off, B1 = 0, the solution of the
above differential equations will be given by
Mx(t) = [Mx(0) cosω0t+My(0) sinω0t] · e−
t
T2 (2.12)
My(t) = [My(0) cosω0t+Mx(0) sinω0t] · e−
t
T2 (2.13)
Mz(t) = Mz(0) · e−
t
T1 +M0
[
1− e− tT1
]
(2.14)
The component of the NMV in the xy-plane, is simply given by
Mxy(t) =
√
Mx(t)
2 +My(t)
2 (2.15)
Substituting for Mx(t) and My(t) from Equations (2.12 and 2.13) in Equation (2.15),
we get
Mxy(t) = e
− t
T2
√
Mx(0)
2 +My(0)
2 (2.16)
Equations (2.12, 2.13, and 2.14) can be utilised to describe the relaxation process
after an RF pulse. Let us assume a 90◦ pulse is applied. Accordingly the NMV will
be flipped onto the xy-plane with its maximum magnitude M0. Whatever the angle it
makes with the coordinates x and y, the NMV is equal to Mxy at time t=0 (just after
switching the RF off). This can be expressed mathematically by
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Mxy(0) = M(0) =
√
Mx(0)
2 +My(0)
2 (2.17)
Equation (2.17) gives us the initial condition just after the 90◦ pulse. Substituting
this in Equation (2.16), the decay in the transverse component of the NMV can be given
by
Mxy(t) = M(0)e
− t
T2 (2.18)
The recovery in the longitudinal component of the NMV is given by Equation (2.14).
Just after a 90◦ RF pulse, the NMV will be totally flipped onto the xy-plane. If we
chose this time to be our (t=0), then Mz(0)=0 and therefore, the first term of Equation
(2.14) vanishes
Mz(t) = M0
[
1− e− tT1
]
(2.19)
The magnitude of the NMV changes with time, so its components are independent
of each other. To understand the independent variation of longitudinal and transverse
components of the NMV, see Fig.2.10. It shows the relaxation process after a 90◦ RF
pulse in the laboratory frame of reference. As illustrated, the NMV precesses around
the z axis in at the Larmor frequency, with its component in the xy-plane decaying
while its component in the z direction z axis is recovering. The recovering and decay
occur with different relaxation times, T1and T2 respectively.
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Figure 2.10: The relaxation as seen from the lab frame. The magnitude of the NMV
does not always equal M0(reference [10]).
2.2.9 Measuring relaxation time
As mentioned above, there are two different types of relaxation. The spin-spin relaxation
time T2 is less than the spin-lattice relaxation time T1. In this section, we will explore
the methods of measuring these relaxation times for a sample.
In order to measure T2, a spin-echo sequence is applied with a range of different echo
times. The signal intensity recorded in the receiver coil will obey Equation (2.18). So,
a curve fit of the experimental data with this equation will provide us with the fitting
parameters (M0 and T2).
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For measuring T1, one might suggest applying a similar method using Equation
(2.19). However, it is not possible practically to measure the magnetisation component
in the z direction. This is because the magnetic field associated with the NMV is much
smaller than the static field which lies in the z direction. Instead, the so called inversion
recovery sequence, is applied. It had actually been used before the days of MR imaging
in NMR experiments for its applicability in measuring T1 for bulk materials. In the
inversion recovery sequence a 180◦ RF pulse is applied, flipping the NMV to the -z
direction. Just after switching the RF pulse off, the recovery process will take place.
This means the component of the NMV in the z direction will be increasing from -M0
towards its equilibrium value of +M0. After a certain time, known as the inversion time
(TI), a 90◦ pulse is applied. This flips the z component of the NMV onto the xy-plane
where it can be detected by the RF coil. This can be followed by a 180◦ pulse to refocus
the signal and generate an echo, just as in the spin echo sequence. The signal intensity
detected by the coil in the inversion recovery method is expressed by [10]
SI(TI) = Mxy(TI) = M0
[
1− 2e−TIT1 + e−TRT1
]
(2.20)
In Equation (2.20), we chose the repetition time to be much longer than T1 of the
sample (TR >> T1), to ensure full recovery. Figure(2.11) shows the time course of
Mz in the inversion recovery experiment. So, a curve fit of the experimental data will
provide us with the fitting parameters (M0 and T1).
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Figure 2.11: The time dependence of Mz in the inversion recovery experiment( [32])
2.2.10 MRI contrast agents
The contrast in an MR image of a biological tissue is mainly due to the spatial variation
in T1 or T2 values. The imaging sequence is said to be T1 weighted if the principal
image contrast relates to T1 values, and T2 weighted if the principal image contrast
relates to T2 values. The imaging parameters, TE and TR, are chosen in such a way
that the image expresses the desired contrast. For instance, a long TE will give T2
contrast (longer T2 appears brighter) and a short TR will give T1 contrast (longer T1
appears darker).
The variation in T1 and T2 are intrinsic properties that depend on the proton den-
sity, inhomogeneity of the magnetic field, and the chemical structure of the sample.
However, magnetic material can be utilised in altering the sample relaxation properties.
Such materials are known as contrast agents. The aim of this section is to understand
how contrast agents work in MRI. This will be achieved by exploring the classifica-
tion of magnetic materials, explaining the contrast mechanism, and the contrast agent
relaxivity [33].
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Magnetic material classification
Materials are classified into three main types for their response to an applied external
magnetic field. The relationship between the magnetic field and the induced magneti-
sation is described by
M = χB (2.21)
The classification is based on the proportionality constant, the magnetic susceptibil-
ity (χ), upon its magnitude, sign, and temperature dependence [34] . These types are
diamagnetic, paramagnetic and ferromagnetic.
Diamagnetic materials do not have unpaired electrons in their outer atomic shell; so,
their atoms do not exhibit any magnetisation when no magnetic field is applied. Their
magnetic susceptibility is negative which means that the induced magnetisation is anti-
parallel to the applied field. However, the magnitude of the magnetic susceptibility of
diamagnetic materials is relatively small, 10−6 to 10−5 [35].
Paramagnetic atoms have unpaired electron in their outer shell. Each atom has a
net magnetic dipole moment. However, the random orientations of the atoms moments
cancel each other; so, the material has no magnetisation in the absence of an external
magnetic field. When a magnetic field is applied, the magnetic moments of the atoms
align parallel to its direction and the material develops net magnetisation. If a para-
magnetic material placed in a non-uniform magnetic field it is attracted toward the
stronger region. When the external field is removed the paramagnetic material loses its
magnetisation.
Ferromagnetic materials are permanent magnets. They have unpaired electrons in
their atoms outer shell, like paramagnet. However, the magnetic moments of atoms
in ferromagnetic materials are arranged in domains due to a quantum effect known as
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exchange coupling.
Contrast agents materials used in MRI belong to the second type, namely param-
agnetic. The mechanism of how these materials enhance contrast of an MR image will
be presented briefly in the following section.
Mechanism of contrast agents
As discussed in previous sections, contrast of an MR image depends on several fac-
tors such as proton density, relaxation times T1 and T2, and imaging sequence and
parameters. Contrast agents shorten both relaxation times T1 and T2 (The detailed
mathematical explanation is quite complicated and it is out of the scope of this thesis.
For further details, the reader is referred to reference [36]). If the T1 and T2 values are
altered by the contrast agents, the image contrast will be altered accordingly as stated
by Equation(2.5) and Equation(2.7).
Relaxivity measurements
The relationship between the relaxation rates 1/T1 and 1/T2 and the concentration of
a contrast agent is linear for relatively low concentration
1
Ti
=
1
Ti0
+ ri [M ] i = 1, 2 (2.22)
where Ti0 and Ti are the relaxation times of the sample before and after adding
the contrast agent respectively, [M] is the concentration of the contrast agent, and ri is
known as relaxivity [36]. Here relaxation times are measured in seconds, the contrast
agent concentration in mM, so the unit of relaxivity is mM−1s−1. Note that this equation
is applicable for both T1 and T2 contrast agents.
In order to determine how a contrast agent is effective in MRI, its relaxivity is
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calculated. Experimentally, this can be achieved by measuring the relaxation times
for different concentrations of the contrast agent either by using the inversion recovery
method for T1, or by spin-echo sequence for T2 as explained in section(2.2.9).
2.3 Optical spectroscopy and microscopy
2.3.1 Introduction
In this thesis, coherent Raman scattering (CRS) techniques are proposed to provide
the complementary microscopic information about the 3D spatial distribution of the
multi-scale nanoparticle contrast agents within a biological context. Also, optical spec-
troscopic methods are adopted to characterise optical properties of nanoparticles. Ad-
ditionally, there are imaging techniques that can be used to image nanoparticles simul-
taneously with the same CRS laser excitations and experimental setup. The aim of
this section is to explore the theoretical background of these spectroscopic and imaging
techniques.
2.3.2 Confocal microscopy
Unlike a conventional optical microscope, the confocal microscope has the ability of
optical sectioning. Only the signal from the excitation focal plane is collected using a
pinhole detection scheme illustrated in Figure (2.12). This allows imaging at depth in 3D
samples. The sample is stained with a fluorophore that absorbs at specific wavelength
and emits light at longer (lower energy) wavelength. The excitation is typically achieved
by employing a short-wavelength (400 -600 nm) visible laser.
The beam is raster scanned over the imaging plane with galvano mirrors and a
dichroic mirror is utilised to isolate the emission beam by reflecting it to a photomulti-
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plier tube. The image is recorded point-by-point with data read out with a computer
and a matrix image constructed. Moreover, 3D imaging can be achieved by moving
the objective lens to focus onto different planes. It is important to emphasize that the
3D confinement of the focal point is achieved by the pinhole setup as shown in Figure
(2.12). The relationship between the emission and excitation is linear. This is important
because another mechanism of the determination of the focal plane will be introduced
later under nonlinear optical microscopes.
Objective
Excitation
Figure 2.12: The principle of confocal microscopy(Figure was adapted from Leica TCS
SP5 User Manual).
A significant limitation of confocal microscope is its inapplicability to scattering
samples. In scattering media, light emitted from the focal plane undergoes scattering
and is also rejected by the pinhole. This can severely reduce image sensitivity and can
lead to high excitation power to obtain sufficient signal-to-noise. Another substantial
limitation is that confocal microscopy relies on a single photon excitation. Accord-
ingly,the excitation occurs in a large volume above and below the focal plane for the
linear proportionality with laser power[see Figure(2.13)]. This results in bleaching of
fluorescent dye even from out of focus lyers when scanning over the sample. Another
limitation of the technique is the necessity to label sample molecules with fluorophores.
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Single photon
Two photon
Figure 2.13: The excitation volume of single photon excitation versus two photon ex-
citation(the figure was adapted from reference [37]). It can be seen that the excitation
in a single photon process occurs below and above the focal plane whereas a point-like
excitation in the focal plane is achieved by the two photon process.
2.3.3 Two photon fluorescence (TPF) microscopy
Two photon fluorescence (TPF) microscopy is based on the principle of nonlinear ex-
citation where molecules are excited via simultaneous absorption of two near-infrared
photons. This results in the emission of a higher energy photon (typically in the visible
range) which is used for image contrast. This is not the case for confocal microscopy
where single photon excitation is used [see Figure (2.14)]. The major advantage of
using near-infrared excitation is reduction of the attenuation and scattering of the ex-
citation light in biological tissue which enhances the optical penetration depth. This
overcomes the major limitation of confocal microscopy. Also, the excitation of two pho-
ton fluorescence occurs only in the focal plane where the light is more intense for the
nonlinear nature of the process. This reduces the photobleaching of the fluorophore [see
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Figure(2.13)].
Figure 2.14: The energy digram of one photon and two photon fluorescence excitation
(the figure was adapted from reference [37])
However, a significant disadvantage of two photon florescence (TPF) microscopy is
the fact that it requires labelling the sample.
2.3.4 Spontaneous Raman scattering
Raman scattering is a type of interaction between light and matter at the molecular
level. It was first reported by the Indian scientist Sir Chandrasekhara Venkata Raman
in 1928 [38]. Photons of a monochromatic light beam experience inelastic collisions with
the molecular bonds resulting in energy shifts either to a lower or a higher energy. The
energy diagram (Fig.2.15)illustrates the interaction processes.
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Figure 2.15: Energy diagram of Stokes and anti-Stokes Raman scattering (υ0 is the
frequency of the incident photon , υm is the molecular vibrational frequency and E0 is
the ground state energy of the molecule).
When a photon is absorb by a molecule in its ground state E0, it is excited to
a virtual electronic energy level and spontaneously relaxes to a vibrational state by
emitting another photon with lower energy. The new photon is red shifted (has lower
energy) with respect to the incident photon and this type of scattering is known as
Raman Stokes scattering. In the second type of Raman scattering, anti-Stokes, a photon
is absorbed by a molecule which is already in the vibrational energy level. Following
excitation to the virtual electronic energy level, it spontaneously decays to the ground
state emitting a photon with higher energy (blue shifted) with respect to the incident
photon. However, anti-Stokes Raman scattering is less probable in thermal equilibrium
(Boltzman distribution).
In both types, the Stokes and the anti-Stokes, the energy difference between the
incident and emitted photons is equal to the vibrational energy of the specific chemical
bond. It is conventional to measure the energy of a Raman shift using wave number
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(cm−1) according to Equation (2.23).
Ω =
∣∣∣∣ 1λin − 1λem
∣∣∣∣ (2.23)
where Ω is Raman shift and λinand λem are the wavelengths of incident and emitted
photons respectively.
Raman scattering is a very powerful tool for chemical spectroscopy in biological ap-
plications, since the spectra of Raman scattered photon can be considered as a molecular
fingerprint of a sample. Moreover, the direct proportionality of the signal to the bonds
concentration allows quantitative analysis [39]. In microscopy, Raman scattering was
utilised for imaging the distribution of bio-molecules with high resolution [40]. However,
Raman scattering has a small cross section ( typically 106 times weaker in biological
tissue when compared to fluorescence) which means utilising it in microscopy requires
long acquisition time of several hours to image biological cells [27].
2.3.5 Coherent anti-Stokes Raman Scattering (CARS)
CARS is a nonlinear optical technique based on the concept of Raman scattering that
was first reported in the American Physical Society journal by Marker and Terhune in
1965 [41]. Instead of one incident laser beam, in CARS two laser beams are utilised
to probe the molecular bond. The process of the energy transitions of the molecule
under the two beams is illustrated in Figure(2.16). When the frequency difference
between the two beams matches a Raman vibrational mode, they drive the molecules
in the excitation volume to oscillate coherently. Three electromagnetic waves (2 of λp
and λs) interact with the medium nonlinearly to induce a fourth wave via third order
polarisation. This can be expressed mathematically by
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P (3)(ωas) ∝ χ(3)E2pEs (2.24)
where P (3)(ωas) is the induced polarisation, χ
(3) is known as the third order electric
susceptibility, and Ep and Es are the electric field of the pump and Stokes respectively.
The intensity of the anti-Stokes is given by [28]
Ias ∝
∣∣χ(3)∣∣2 I2pIs(sin(∆kz/2)∆k/2
)2
(2.25)
Figure 2.16: Energy diagram of CARS. Two pump photons of angular frequency (ωp)
and a Stokes photon of angular frequency of (ωs) are involved in the generation of an
anti-Stokes photon of angular frequency of (ωas).
where Ias is the anti-Stokes signal intensity,χ
(3) is the third order electric suscepti-
bility, Ip and Is are the intensities of the pump and Stokes beams, respectively, z is the
sample thickness, and ∆k is the phase difference. It can be seen that the anti-Stokes sig-
nal is proportional directly to the square modulus of the third order susceptibility. This
indicates that the CARS signal is proportional to N2, where N is the number of oscilla-
tors in the excitation volume, since χ(3) ∝ N . The signal is generated coherently from
the oscillators and constructively interfere providing CARS with its higher sensitivity
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when compared to spontaneous Raman scattering [28, 42, 43]. The non-linear depen-
dence on excitation allows further enhancement by pulsed excitation. In Equation(2.25)
∆k is given by
∆k = kas − (2kp − ks) (2.26)
In order to generate a maximum anti-Stokes signal from the excited volume ∆k is re-
quired to be close to zero. This is known as phase matching condition(see Figure(2.17)).
For CARS spectroscopy, the phase matching condition is obeyed by controlling the angle
between the two incident beams in a 2D configuration. However, the phase matching
condition was the challenging obstacle to employ CARS in imaging.
Figure 2.17: Phase matching condition in the (a)forward and (b)backward CARS.
It was not until 1999 that CARS was first implemented in microscopy [42]. This
was achieved by tight focusing of collinear-aligned beams with high numerical aperture
lenses to satisfy the phase matching condition. Since then, CARS microscopy has been
utilised in biomedical applications [28].
Even if the difference between the two beams frequencies is chosen to be far from the
Raman resonance frequency of a Raman active medium, there will be a signal generated
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as a result of a response from the electrons. This contribution is independent of wave-
length and known as the non-resonance background. When the frequency difference
(ωp − ωs) is tuned to match the Raman vibrational frequency, the anti-Stokes signal
is enhanced by the resonance contribution. Accordingly, it can be assumed that χ(3)
consists of two components [28] stated by
χ(3) = χ
(3)
NR +
χ
(3)
R
∆− iΓ (2.27)
where χ
(3)
NR is the non-resonance component, χ
(3)
R is the resonance component, ∆ is
the detuning, and Γ is the bandwidth of a Raman peak. The detuning is given by
∆ = (ωp − ωs)− ΩR (2.28)
In Equation(2.28) ΩR is the Raman shift and the value of ∆ is zero at the resonance
condition.
As mention above, the CARS signal intensity is proportional quadratically to χ(3).
Considering the resonance and non-resonance component Equation(2.27), the propor-
tionality can be expressed as
ICARS(∆) ∝
∣∣∣χ(3)NR∣∣∣2 + ∣∣∣χ(3)R (∆)∣∣∣2 + 2χ(3)NRReχ(3)R (∆) (2.29)
The physical concept of Equation(2.29) is illustrated in Figure(2.18). Each term of
the equation is plotted as a function of ∆ in Figure(2.18 a). The first term,
∣∣∣χ(3)NR∣∣∣2,
does not change when changing the detuning over a Raman vibrational mode, whereas
the second term behaves like a spontaneous Raman peak. The third term is dispersive
around ∆ = 0, which influences the addition of the three terms(Figure(2.18 b). Ac-
cordingly, the detected CARS signal peak is red shifted when compared to spontaneous
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Raman. It also has a dip on the blue end of the peak which creates negative contrast
of the active Raman medium( the black holes in Figure(2.18 e)).
Figure 2.18: Resonance and nonresonance CARS (the image was taken from [28]). In
image (a), the straight horizontal line represents the nonresonance term of Equation
(2.29), the solid line peak-like curve corresponds to the second term of the equation,
and the dashed curve represents the third term of the same equation. In image (b) the
summation of the three terms of the equation is plotted and the images (c), (d) and
(e) are CARS images of a biological cell with the correspondent detunings hilighted in
image (b).
The signal of CARS microscopy can be detected in the forward and backward(epi)
directions. Due to the coherent nature of signal generation unlike linear techniques such
as Raman and fluorescence, CARS signal is directional. The strength of the signal in
the forward and backward directions depends on different parameters. For a very thin
object, the signal is equally generated in forward and backward directions. However,
the forward signal gains more intensity for larger objects, whereas the backward signal
decreases. This has special practical implication for epi CARS microscopy [44]. First,
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objects in the size range of λ/3 generate backward signal because their size is not enough
for the generated signal to interfere destructively [45]. Second, the sharp discontinuity
in the third order susceptibility χ(3)in the focal volume permits higher backward sig-
nal. The third mechanism occurs in highly scattered medium, medium with continuous
change in the refractive index, where the forward signal redirected toward the backward
direction.
2.3.6 Four wave mixing (FWM)
As mentioned in the previous section there is a non-resonance signal generated in the
focal volume (see Equation.2.27 and Figure.2.18). This signal is a result of a more
general form of four wave mixing processes where three waves contributes in generating
the fourth and it is independent of the Raman resonance mode. Nanoparticles of high
third order susceptibility such as some metal oxides can be imaged with the FWM
mechanism [46]. Moreover, the nanoparticles could be imaged in the biological tissue.
The distinguishable contrast of the particles against the biological tissue is achieved by
tuning the laser wavelength away from Raman resonance of CH bonds in lipids. The
nanoparticles will still possess a strong FWM signal because of their high third order
susceptibility and condensed nature.
To the best of the author’s knowledge, there is only one study which investigated
the possibility of imaging magnetic particles with the FWM process. In 2011, Rago and
coworkers imaged iron oxide microparticles in biological cells [30]. Figure.2.19 shows
three images of micro-sized iron oxide particles where (a) is a bright field image, (b) is
an on-resonance CARS image where pump and Stokes tuned to target CH bonds and
(c) is an off resonance image of the particles. As stated by the authors, the signal of (b)
and (c) is due to different excitation power driven of the OPO, hence otherwise, both
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on-resonance and off-resonance are physically expected to generate the same signals.
5µm
Figure 2.19: Imaging iron oxide micro-particles, a) transmission light, b) on resonance
, and c) off resonance FWM.
However, it is more practical for drug targeted delivery for the particles to be of
smaller size, namely, in the nanometer scale, especially in the case of solid tumours [47].
This is due to the diffusion process which was widely discussed in the literature as a way
to deliver specific medicine and contrast agents to tumours where the vascular structure
is leaky for such small particles. In this study the FWM will be considered as one of
the available techniques for imaging magnetic nanoparticles.
2.3.7 Stimulated Raman Scattering (SRS)
When targeting a Raman vibrational mode using CARS, different processes occur si-
multaneously in the focal volume. One important process is the stimulated Raman
scattering (SRS)( see the energy diagram Figure(2.20)). The molecules excited with
the pump beam reach a virtual electronic state. If the sample is not subjected to
another laser beam(the Stokes in this case), the molecules will spontaneously radiate
photons in the Stokes frequency. This is exactly what occurs in the spontaneous Raman
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process. However, in the presence of the Stokes beam the molecules are stimulated to
radiate their energies resulting in a gain in the Stokes intensity(SRG) and a loss in the
pump intensity(SRL). This process is known as stimulated Raman scattering.
Figure 2.20: Stimulated and spontaneous Raman scattering
In order to detect this small change in the intensity, one of the beams is amplitude-
modulated in a certain frequency and the intensity of the other is measured with a lock-in
amplifier fitted after the sample. The Stokes will experience a loss that occurs in the
same modulation frequency and a loss will be observed in the pump beam. Figure(2.21)
illustrates the molecular transfer process for SRL detection when the Stokes beam is
modulated.
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Figure 2.21: The loss and gain in the stimulated Raman scattering,adapted from [48].
The remarkable advantage of SRS comparing to CARS is the absence of the non-
resonance background. Also, SRS is linearly proportional to the oscillators concentra-
tions which permits utilising it in quantitative analysis.
2.3.8 Two Photon Photothermal lensing (TPPL)
Two photon Photothermal lensing microscopy is a method that maps the features of
a sample via its nonlinear optical absorption. The sample is subjected to two beams
focused with an objective lens. One of the beams (the pump) is absorbed nonlinearly
by the sample in the focal point as an excitation of atoms to an electronic state. The
absorption will generate heat that has gradient around the focal point causing a gradient
in the refractive index. This causes the focal point to work as a lens. If the pump beam
is modulated at certain frequency the lens effect will be modulated accordingly. The
second beam experiences a lensing effect at the modulation frequency that causes its
diameter at the detector to modulate. For a small aperture detector this changing in
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diameter results in an intensity modulation in the probe signal [49]. Like SRS, the
fluctuations of the probe signal intensity can be detected with a lock-in amplifier, and
it can be given mathematically by [50]
S ∝ I
2
ex · Ipr · σ2−p · [c] · ηH
λpr · κ
(
dn
dT
)
p
(2.30)
where S is the detected signal, Iex and Ipr is the pump excitation and the probe
intensities respectively, σ2−p is the two photon absorption cross section, [c] is the sam-
ple concentration, ηH is the yield of heat dissipation, λpr is the probe wavelength, κ
is the thermal conductivity, and
(
dn
dT
)
p
is the rate of change of refractive index with
temperature at constant pressure.
2.3.9 Photoluminescence (PL)
Luminescence is an optical effect that generates light from a material via spontaneous
emission. The emission is a result of an excitation that can occur in different ways. The
excitation could be via a chemical reaction(chemiluminescence), electric field( electro-
luminescence), and so on. If the excitation occurs through light absorption, the process
is known to be photoluminescence(PL). The term photoluminescence is conventionally
used when an ultraviolet or visible photon excite the material to generate another photon
of lower or equivalent energy. For solid state materials, there are two main categories in
which the photoluminescence occurs: localised and delocalised systems. In the localised
systems, the absorption and emission arise from quantum energy state centres within
the material. Examples of the these active localised luminescent centres are rare earth
ions and transition metal ions. Isolating materials or wide band gap semiconductors are
doped with these ions and the luminescence properties depend on both the ions and the
host materials. Another example of the localised centres systems is defects in solids.
49
Chapter 2. Background Theory
In the second type, the delocalised materials, the luminescent properties are associated
with the entire solid quantum states [51]. The photoluminescent materials investigated
in this thesis belong to the localised luminescent centres systems type where a large
band gap crystal is doped with rare earth ions.
The mechanism in which PL occurs in doped large-band-gap semiconductors is ex-
plained in detail by Belsky and Krupa [52]. In brief, doping such large band gap
semiconductors with rare earth ions generates possible energy states within the band
structure. The excitation occurs via a direct absorption either by the luminescence
centres or by the host lattice. In both cases a portion of the absorbed energy is then
re-emitted in the form of lower energy photons. The luminescence can be used as a
fingerprint for the doping ions.
2.3.10 Upconversion Photoluminescence (UPL)
Upconversion Photoluminescence is a nonlinear optical process in which two or more
infrared photons are involved in generating a photon in the visible spectrum. How-
ever, unlike other nonlinear processes, upconversion can occur even with low intensity
excitation with the benefit of two or more metastable long-lived energy states. The
mechanisms of upconversion can be classified into four main types: excited state ab-
sorption(ESA), cross relaxation(CR), energy transfer upconversion (ETU), and photon
avalanche (PA) [53] (See Fig.2.22).
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Figure 2.22: UC processes a) excited state absorption, b) cross relaxation, c) energy
transfer upconversion and d) photon avalanche.( The figure is adapted from [53])
In ESA the ion is excited from its ground state E1 to an energy state E2 after
absorbing an infrared photon. Because the new energy state has a long lifetime, there is
a high probability for another photon to excite the ion to a higher energy state E3. When
the ion relaxes back to its ground state it emits a photon with the energy (E3 − E1).
In the cross relaxation process two ions are excited to an energy level E2. Afterwards,
one of the ions relaxes to its ground state through transferring energy to the other
ion which absorbs the energy and is consequently excited to E3. A photon is emitted
with energy equivalent to (E3 − E1). Three ions are involved in the ETU, where two
ions(known as the sensitizers) are excited to E2 via absorbing infrared photons. They
both transfer energy to a third ion (known as the activator) which is excited accordingly
to E3 and spontaneously emits a visible photon [54,55]. The last mechanism occurs when
the intensity of the excitation reaches a threshold value, where many ions jump to E2
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through nonresonant excitations. Because a considerable number of ions are in the
energy state E2, a resonance ESA occurs for photons with energy (E3−E2) populating
the energy level E3. As more and more ESA events take place, ions exited to E3
transfer energy to surrounding ground state ions resulting in a further increment in the
E2 population. A much stronger UC can be detected above the excitation intensity
critical level [56].
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Chapter 3
Method and Instrumentation
3.1 Introduction
Several spectroscopic and imaging techniques are utilised to achieve the goals of this
thesis; label free imaging of the biological tissue and imaging magnetic nanoparticles on
multiple scales. The theoretical backgrounds of these different techniques were covered
in the previous chapter. In this chapter, the experimental techniques and methods used
to implement them experimentally will be presented.
3.2 Magnetic Resonance Imaging
All the MRI data for this project was acquired at Exeter MR Research Centre. The
center is equipped with a Philips 1.5 T clinical whole-body scanner. A head coil (
SENSE Head coil 8 elements ) was utilised to conduct the T1 and T2 measurements
for the different MRI contrast agents. For the high resolution imaging, and detailed T1
and T2 mapping, a 23mm microscopy coil is used providing high signal-to-noise ratio.
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3.3 Optical setup
3.3.1 Raman Spectroscopy and Photoluminescence
The Raman spectroscopy and the photoluminescence spectroscopy in this thesis were
performed using a Renishaw RM1000 Raman micro-spectrometer Figure.3.1 (Renishaw,
Wooton-Under-Edge, UK). The micro-spectrometer was modified between two available
configurations. The first is achieved by utilising an infrared continuous laser source
emitting at 785 nm and a 1200 line/mm grating, which provides spectral resolution of
1 cm−1. In the second setup, a 532 nm green continuous laser is implemented with
a 2400 line/mm providing approximately the same spectral resolution. The spectral
acquisition parameters such as the illumination power, time of each scan and number of
scans was controlled with Renishaw v.1.2 WiRE software. The microspectrometer was
equipped with number of different objectives: 50x/0.75NA , 40x/0.55NA, 20x/0.40NA
and 5x/0.12NA.
Figure 3.1: Image of the Raman spectrometer (RM1000).
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Figure 3.2: Sketch of the optical setup of the Raman spectrometer (RM1000).
The system is calibrated before each experiment using the well known strong silicon
peak at 520 cm−1 as a reference.
3.3.2 Confocal microscope
The upconverting nanoparticles were imaged using a Leica TCS SP5 confocal micro-
scope. The microscope is equipped with eight CW laser sources emitting from blue
to green (Diode laser: 405 nm, Multiline Argon Laser: 458 nm, 476nm, 488 nm, 496
nm, 514 nm, 543 nm and HeNe Laser: 633 nm). Also, a tuneable acousto-optic filter
provided flexibility of the emission. Three photomultiplier tubes are fitted in the optical
setup of the microscope to provide three possible imaging channels. In a typical exper-
iment, two channels are used to detect two tuneable ranges of the emission spectrum
and the third detects the transmission light image.
In order to image the doped gadolinium oxide nanoparticles, two laser lines of the
Argon laser are utilised (458 nm). A 63x oil immersion objective lens with numerical
aperture of 1.4 was used. The detection spectrum of the two channels were determined
according to the expected PL emission of the particles. All the imaging parameters were
computer-controlled using the manufacturer software (Leica Application Suite Advanced
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Fluorescence (LAS AF).
3.3.3 Coherent anti-Stokes Raman Scattering
Coherent anti-Stokes Raman scattering is a nonlinear optical mechanism that requires
an ultra-fast pulsed laser. The laser source is a solid state Nd:Vanadium laser (High-
Q Picotrain, Hohenems, Austria). An infrared 6 ps pulsed beam train is obtained at
1064 nm and frequency doubler generates green 532 nm light with output power 4 W.
The system repetition rate is 76 MHz. The 1064 nm beam can be used directly from
the source and the 532nm is used to pump an optical parametric oscillator (OPO) to
produce two tuneable near infrared beams. These two beams are known conventionally
as signal(the shorter wave length) and the idler. The range of wavelength of the signal
and idler are from 690 nm to 990 nm and 1150 nm to 2300 nm, respectively. The output
beams are steered on the optical bench with silver mirrors configured in such a way as to
ensure that the beams are spatially overlapped in a colinear manner. The pulse trains
of the two beams are temporally overlapped by changing the length of the optical path
of one of them using a delay stage(see Fig.3.3), so that pump and Stokes arrive at the
microscopy simultaneously.
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Figure 3.3: The optical setup of CARS microscopy [48]
The spatially and temporally overlapped beams are directed into a modified laser
scanning microscope. (Olympus IX71 & FU300) which had silver galvanometric mirrors
and MgF2 coated lens to improve optical transmission in the near IR.
There are two available CARS setups to image biological structures by targeting the
CH Raman vibrational mode at 2848 cm−1. The first is by utilising signal and idler
beams as pump at 924 nm and Stokes at 1254 nm respectively. For this configuration,
a 850nm long wave pass diachronic mirror (z850rdc-xr, Chroma Technologies) is placed
before the objective lens to allow epi-detection. The transparency profile (and hence
oppositely the reflectivity) of the mirror is illustrated in Figure.3.4.
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Figure 3.4: The transparency of the dichroic 850nm long-pass mirror (provided by the
manufacturer)
For the forward detection, the signal is collected with an air condenser (NA=0.55),
reflected with a mirror and filtered with a band pass filter (HQ750/210, Chroma Tech-
nologies). The transparency profile of the 750 nm band-pass filter is provided by the
manufacturer in Fig.3.5.The signal is then collimated with a lens and detected with
a red-sensitive photomultiplier tube (PMT) (R3896, Hamamatsu). Fig.3.6 shows the
sensitivity profiles of two models of PMT from the same supplier. The sensitivity of the
R3896 is considered when quantitative or qualitative comparison is required. The epi
signal is collected by the objective lens and reflected with the 850nm long wave pass
dichroic mirror into another R3896 PMT fitted in the back of the microscope. Another
band pass filter (HQ750/210, Chroma Technologies) is used to isolate the anti-Stokes
signal in the epi-direction.
The second available CARS setup for CH imaging at 2848 cm−1 is obtained by
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employing the signal at around 816 nm and the 1064 nm beams as pump and Stokes
respectively. For this choice, a 750 nm long wave pass dichroic mirror (Chroma) is
placed before the objective lens. The epi-CARS is only collected with the objective lens
and reflected with the dichroic mirror through two 660 nm band-pass filters (CVI). The
signal is collimated with a lens and detected with the R3896 photomultiplier tube.
Figure 3.5: The transmission profile of the 750/210 nm band pass filter (provided by
the manufacturer)
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Figure 3.6: The cathode radiation sensitivity of the PMT (R3896, Hamamatsu) as a
function of wavelength (provided by the manufacturer)
3.3.4 Stimulated Raman Scattering
Stimulated Raman scattering is detected with a similar optical configuration to the sec-
ond CARS setup explained in the previous section. However, a Pockels cell (EM200,
Leysop, UK) and a polariser are placed in the optical path of the 1064 nm beam to mod-
ulate its amplitude at 1.7 MHz importing the signal from a function generator(Agilent).
The forward signals are collected using either the (0.55 NA) or another objective lens
(Nikon Fluor 60 x, 1.0NA) for a higher sensitivity detection. Then a band-pass filter
(Chroma, CARS 890/220 nm) is utilised to isolate the pump beam from the Stokes
signal. The modulation of the pump signal intensity resulting from the SRL is detected
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with a Si photodiode (Thorlabs, FDS1010). The electric current generated in the de-
tector is filtered with a low-frequency pass filter (Mini-Circuits, BLP-1.9+) in order to
suppress the strong signals generated due to the laser pulsing at the repetition rate 76
MHz. The signal is amplified with a lock-in amplifier (Stanford Research, SR844RF)
referenced to the signal generator frequency 1.7 MHz. The modulation frequency is
chosen to be far away from the laser relative intensity noise (RIN).
3.3.5 Two Photon Photothermal Lensing (TPPL)
The two photon photothermal imaging of the red blood cells and iron oxide nanoparticles
was achieved by utilising the same setup used from SRS. However, as demonstrated in
Section (2.3.8) the mechanism of TPPL is completely different form SRS. Consequently,
different experimental parameters have been adjusted in order to enhance the quality
of the background free image. This includes the modulation frequency, the temporal
desynchronisation of pump and Stokes beams and aperture size of detection optics. The
modulation frequency is controlled with the function generator and the delay stage of
the 1064 nm beam is used to control the temporal overlapping of the two pulse trains.
Finally, the aperture size of the detected beam is adjusted using a iris diaphragm.
3.3.6 Upconversion spectroscopy and imaging
For the upconversion spectroscopy, a single excitation picosecond or femtosecond (Co-
herent, MIRA) pulsed beam is used. The spectroscopy of the upconverting doped
gadolinium oxide particles is performed by scanning them with the microscope. A
polarising beam splitter is placed before the microscope to reflect portion of the back-
ward collected signal to another optical path toward a spectrometer (Andor Technology,
Shamrock sr-303i).
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Figure 3.7: The additional setup required for UC spectroscopy and imaging of the doped
gadolinium oxide particles
Before interesting the spectrometer the beam is filtered with a proper short-wavelength
pass filter to suppress the excitation beams. Then a collimating lens is used to focus the
light into the spectrometer aperture. The schematic of the optical setup is presented
in Fig.3.7. The spectrometer is equipped with three gratings with different lines per
mm providing three different resolutions and coverage ranges. Figure (3.8) shows the
interior setup of the spectrometer.
CCD 
camera
Three!
diffraction !
gratings
Figure 3.8: The interior setup of the Andor spectrometer.
62
Chapter 3. Method and Instrumentation
3.4 Nanoparticles fabrication and Characterisation
3.4.1 Fabrication
Two main types of particles have been fabricated. A Precipitation method was used
to synthesise gadolinium oxide doped nanoparticles, whereas iron oxide nanoparticles
were fabricated by hydrothermal method. The detailed processes of both methods are
explained in the two following sections.
Homogeneous precipitation method
Lanthanide doped gadolinium oxide nanoparticles were synthesised using the homoge-
nous precipitation method. The raw material, Gadolinium(III) nitrate hexahydrate
(Gd2(NO3)3·6H2O, 99.9%), ytterbium(III) nitrate pentahydrate (Yb2(NO3)3· 5H2O,
99.9%), Erbium(III) nitrate pentahydrate(Er2(NO3)3·5H2O , 99.9%) and Urea powder
(BioReagent) were bought from Sigma-Aldrich (UK). An amount of 1.68 m mol(0.758
g) of gadolinium nitrate was added to 300 ml of distilled water in a beaker placed on
a hot plate. Because erbium and ytterbium work as dopant ions, only minute quan-
tities of their nitrate are added as molar percentages. For instance, when fabricating
Gd2O3:1%Yb
+3, 1%Er+3, about 0.0075g (0.0168 m mol) of the nitrate of each dopant is
added. The solution is stirred vigorously at room temperature with a magnetic stirrer
for 50 min to ensure a complete dissolving and homogeneous distribution of the different
ions in the solution. Then, 9 g of urea is added while continuing the stirring for an-
other 10 min at room temperature resulting in a transparent solution. The transparent
solution is then heated with the hot plate at an average rate of 3 ◦C/min and then,
maintained at 85 ◦c for 30 min. After reaching the nucleation temperature (85 ◦c), a
lower transparency of the liquid is observed resulting in a milky colour, which suggests
formation of nanoparticles. The nanoparticle powder is then isolated using centrefusion
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with rotation speed of 600 r/m for 10 min. After centrefusion, the powder is left to
dry overnight in an 80 ◦c oven. In order to enhance the crystalline structure of the
nanoparticles, the powder was then annealed at 950◦ for 30 min.
The procedures mentioned above are similar to that reported by Hemmer et. al. [57].
However, here I have controlled the particle size by varying the nucleation time.
Hydrothermal method
In this method, 6.6 g of iron chloride (Sigma Aldrich, UK) was dissolved in 20 g of dis-
tilled water at room temperature resulting in 2.60 Molar yellowish iron chloride solution.
This solution is kept in a tightly closed container to prevent altering the concentration
via water evaporation and used later as starting solution for all the iron oxide synthesis
experiments.
In order to achieve the high pressure and temperature required for the hydrothermal
synthesis, Teflon-lined steel autoclaves were used Figure (3.9). The 2.6 Molar iron
chloride was diluted to different lower concentrations in order to fabricate different size
iron oxide nanoparticles. Then, 40 ml of the diluted solution was mechanically stirred
inside the autoclave. Afterwards, the autoclave was sealed tightly and inserted into a
furnace with a controlled temperature at 160◦ for 120 min. The autoclave was taken out
of the furnace and left inside a fume hood to cool down naturally at room temperature.
The nanoparticles were obtained from the resulting liquid by the centrefusion process
mentioned in the previous section.
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Figure 3.9: Teflonlined steel autoclaves used for hydrothermal synthesis method.
3.4.2 Characterisation
Scanning Electron Microscope (SEM)
In order to characterise the morphology and size of the nanoparticles a scanning electron
microscope(Hitachi S-3200N SEM, Japan) was used. The instrument is capable of
acquiring images with a resolution up to 3.5 nm in magnification range of 20-300,000
x. Because the nanoparticles used for this thesis are semiconductors, a carbon tape or
conducting gold coating is applied.
The SEM is equipped with Energy Dispersive Spectroscopy (EDS). This was utilised
to confirm the constituent material of the fabricated nanoparticles although, it only
provides a semi-quantitative knowledge about the percentages of the dopant materials.
Transmission Electron Microscope (TEM)
For a higher resolution characterisation of the morphology and size of the nanoparticles
a transmission electron microscope( JEM-2100 LaB6 200 kV TEM) was used. This was
also used to confirm the crystallinity phase of the nanoparticle material.
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X-ray Diffraction (XRD)
The X-ray diffraction was performed with a Bruker D8 Advance XRD (School of En-
gineering, University of Exeter). The measurements were taken of the particles in the
powder form and the data was analysed with DiffracPlus EVA software combined with
the PDF4+ database. This allowed the phase of the nanoparticles as well as the possible
elements making up the crystal to be determined.
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Chapter 4
Label-free Imaging of Tumours
4.1 Introduction
As stated in the introduction, one of the ultimate goals of this study is to suggest a
practical method to investigate the distribution of anti-cancer nano-medicines in brain
tumours. It is proposed to employ multi-contrast magnetic particles as tracking agents
to understand the distribution of particles. This allows MRI to localise the particles
distribution on the whole body scale and at the cellular level with nonlinear optical
microscopy which could be used to provide new information on the bioavailability and
accumulation of particles at multiple scales to aid the rational engineering of enhanced
anti-cancer nano-medicines.
In this study, the role of the nanoparticles is not to enhance the contrast between
healthy and diseased tissue, but to highlight the location of particles within tissue.
Consequently, the contrast between the healthy and diseased tissue should be provided
by the MRI and CARS in a label-free manner. Armed with this label-free contrast
between the healthy and diseased tissue, the distribution of the nanoparticles can be
assigned to the biological context, revealing valuable information. For instance, at the
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MRI scale, one can tell if the nano-medicine is located in the targeted organ (the brain in
this study) in appropriate concentrations, and whether or not the medicine has reached
the tumour tissue. This can be achieved by imaging the animal before and after the
administration of the nano-medicine. At the cellular level, CARS and other nonlinear
optical microscopies can be used to determine whether particles crossed the blood-brain
barrier and the cell type in which the particles reside.
The mouse is a common model animal in which to investigate tumour response to
medicine [58]. One of the methods used to investigate the pharmacological effect in the
literature is to assess tumour growth by measuring its volume. To be able to measure
tumour volume accurately using MRI, it is necessary that tumour and healthy tissue
can be clearly distinguished in the 3 D MR image, and that the edges of the tumour
are sharp and well defined. To investigate this topic and contribute to the overall goals
of the present study, a collaborative study with the London School of Pharmacy was
undertaken, evaluating the effects of three different medicines on tumour growth.
This chapter explores the strengths and limitations of label-free imaging of mouse-
brain tumours using MRI and CARS . The work includes optimisation of the imaging
setup and parameters, to allow healthy and diseased brain tissue to be distinguished
in both techniques. Also, a comparison of the high resolution MRI and conventional
histology volume measurements is presented. Moreover, a novel method is proposed to
correlate the images of the different-scale imaging modalities (MRI and CARS).
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4.2 MRI of mouse brain tumour
4.2.1 Introduction
As discussed in Section (4.1), label-free imaging of the brain is required with contrast
between healthy and diseased tissue. For this purpose, the MR imaging setup and
parameters were optimised to enhance this contrast. Moreover, because tumours in
mouse brain are relatively small in size, on the order of a few cubic millimetres, high-
resolution imaging is required to achieve a reasonable error in volume measurements.
For MRI, there is a trade-off between image resolution and image noise, and it
can be a major challenge to achieve both high-resolution images with high signal-to-
noise ratio (SNR) [59]. In general, there are a number of parameters that affect the
SNR. Firstly, SNR depends on the strength of the static magnetic field in the imaging
hardware setup. As discussed in Section (2.2.4) in the background theory chapter, there
is an advantage of having larger population inversion of the spin states, according to
Equations (2.2 and 2.3). The relationship between the SNR and the static field is more
than linear [60]. However, the disadvantages of utilising higher static field are the cost
of magnets, the relatively high RF power required for imaging, the potential effects of
the high RF power and strong field on biological subjects and the artefacts resulting
from inhomogeneity [59]. As mentioned previously, a 1.5 T static field was available for
the present study.
The second factor is the size of the receiver coil: SNR is inversely proportional to coil
diameter [60]. Despite its small field of view and receptive volume, a smaller coil will be
closer to the imaged voxel resulting in a stronger signal; the detected signal intensity is
inversely proportional to the square of the distance from the voxel to the receiver [61].
The third factor affecting the SNR is the overall imaging time (signal averaging time),
which affects SNR not only in MRI but also in other imaging techniques. In most in
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vivo experiments, the overall time that an anaesthetised animal can be kept still inside
the scanner is limited, but for ex-vivo studies longer acquisition time can be used.
Fourth, the imaging sequence and parameters, such as TE and TR, play an important
role in the SNR. Finally, the fifth factor is the abundance of the targeted nucleus in voxels
of interest and its T1 and T2 values. As a consequence of proton abundance, the voxel
geometrical volume (i.e. the 3D resolution) affects the SNR in a linear proportionality.
For instance, if the voxel dimensions in a 3D MRI image are reduced from 2×2×2mm3
to 1×1×1mm3 the signal intensity is reduced by a factor of 8 [61]. If a short-T1 tissue is
imaged with a T1-weighted sequence the SNR is expected to be higher than for long-T1
tissues. Similarly, if a short-T2 tissue is imaged with a T2-weighted sequence the SNR
is expected to be lower than for long-T2 tissues.
It can be seen that the parameters mentioned above can be classified into two cat-
egories. 1) Extrinsic parameters: hardware setup factors and imaging parameters. 2)
Intrinsic parameters: properties of the sample that appear to be difficult to manipulate.
However, by administration of contrast agents T1 and T2, (2) can be changed allowing
more optimisation of SNR.
There are numerous studies in the literature which involve assessment of the tumour
volume in response to different therapeutic remedies. One of the methods used is his-
tology volume measurement: the tumorous brain is sliced and stained, then the largest
tumour diameter is measured. Assuming that the tumour has a spherical shape, the
volume is then calculated. For example, in 2009 Schauff et. al. [62] implemented this
method to study the impact of gamma radiation and furegrelate on U78 tumour growth
in mice. They claimed that a significant decrease in tumour volume was detectable for
treated mice against those from a control group. However, the accuracy of this method
is questionable since the tumour does not necessarily form a spherical shape (or even
an ellipsoid), as illustrated later in this chapter.
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In order to achieve the highest possible resolution with reasonable acquisition time
for in vivo experiments, a range of different imaging setups have been investigated. In
several of these studies, small-bore systems with high static magnetic fields (>3T) have
been used to obtain high SNR. In 2012, Kerl et. al. [63] used a 9.4 T MRI scanner with
a bore diameter of 20 cm to optimise a fast imaging sequence to measure a type of skin
tumour. Without administration of contrast agent they could achieve edge detection
for subcutaneous tumours in a 30 min scan with a spatial resolution of 120 × 100 × 375
µm3. However, it is less challenging to determine the extent of an under-skin tumour
than a brain tumour in its inhomogeneous context. In another study, McDaniel et.al.
investigated the effect of ischaemia (shortages in blood supply to tissue) on the volume
of different types of brain tissue using a 7 T scanner with a 15 cm bore [64]. Using
diffusion contrast they could determine the interface surfaces between different brain
parts and hence were able to measure volumes with a resolution of 58 × 58 × 469 µm3.
Sun et. al. [65] injected a mouse with contrast agent (Gado- pentetate dimeglumine
(Gd-DTPA)). This was followed by T1-weighted imaging of the brain with a 8.5 T
scanner, 9 cm bore, combined with a 3 cm RF receiver coil. They could detect the U87
tumour boundaries with a resolution of 200 × 200 × 750 µm3. Nelson and coworkers [66]
used a gadolinium-based contrast agent to enhance tumour contrast in the mouse brain,
imaged with a 8.45 T scanner and a 25.6 mm RF coil. Processing post-contrast T1-
weighted images, they measured tumour volume with a resolution of 200 × 200 × 750
µm3. Similarly, using a 7 T scanner and custom-built solenoid coil, Holmes et al. [67]
imaged contrast-enhanced flank tumour with high spatial resolution (60 × 60 × 60 µm3)
.
Despite the advantages of small-bore high-field scanners for mouse brain imaging,
whole-body clinical systems (commonly 1.5 or 3 T) are more available to researchers.
Consequently, a number of researchers have reported the applicability and efficacy of
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clinical scanners in small-rodent brain imaging. In 2011, Pillai and coworkers [68] de-
veloped a volume RF coil to image small-animal brains with a 3 T clinical scanner.
They measured mouse tumour volume with a resolution of 200 × 200 × 1000 µm3 from
T2-weighted images. In a similar study, a 3T clinical system was used with a 4 cm
diameter RF coil to image rat brains after injecting the rat with contrast agents [69].
The tumour volume was calculated with in-plane resolution of 78 × 78 µm2 and slice
thickness of 1 mm.
In 2010, Matoba et. al. [70] monitored the effects of radiotherapy on tumour growth
in rabbits using a 1.5 T clinical scanner and a 4.5 cm surface coil. Without contrast
agent administration they acquired T1- and T2-weighted images of brains with a spin-
echo sequence (with TE/TR=500/20 ms and TE/TR=2000/70 ms, respectively) with
spatial resolution of (200 × 200 × 3000 µm3). The tumour growth was analysed by
measuring the diameter of the largest tumour slice from the T2 weighted images (similar
to the histology method described above). Although this resolution might be sufficient to
detect the volume variations in the relatively larger rabbit tumours, it is not appropriate
for mouse tumours where smaller volume errors are required. Moreover, the capability
of MRI to reconstruct the full 3D shape of the tumour was not utilised.
In order to demonstrate the applicability of high resolution MRI to small animal
studies, Brockmann et. al. utilised a 1.5 T clinical system with a small loop coil to
measure mouse tumour volume after administration of contrast agent [71]. The tumour
volume was measured by summing the areas of all tumour slices from the contrast
enhanced MR images (the in-plane resolution was 160 × 160 µm2 and the slice thickness
was 1 mm). In a further study in 2011, Brockmann [72] analysed the influence of platelet
count on U87 tumour growth with the same imaging method.
Linn et. al. [61] utilised a 1.5 T clinical scanner with a small loop coil and double
array coil to optimise 3D imaging of tumour volume in rat brains. They used a 3D-
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contrast interference steady-state (3D-CISS) sequence and a 3D magnetisation-prepared
rapid gradient-echo (3D-MP-RAGE) sequence with resolutions of 600 × 300 × 500 µm3
and 800 × 800 × 800 µm3 respectively. The image processing was carried out manually
and in a semi-automated segmentation to determine tumour boundaries. In another
study, a simple solenoidal RF coil was developed in order to achieve multiple-mouse
imaging using 1.5 T clinical system [73]. The largest tumour diameter was estimated
from post-contrast 3D T1-weighted spin-echo images with a resolution of 313 × 417
× 1500 µm3 and compared with histology. Similarly, Raila et. al. [74] employed a
wrist coil and contrast media to study rat brain tumours in a 1.5 T clinical scanner.
The tumour volume was measured from post-contrast T1-weighted images by threshold
segmentation.
A number of studies from those mentioned above have examined the reliability of
MRI in measuring tumour volume by comparing the volumetry result with histology
[66, 68, 70, 73]. In all cases, good statistical agreements between the two methods were
reported. However, from a theoretical perspective, MRI data should provide more
accurate volume measurements if the image sequence is optimised to allow accurate
visualisation of tumour boundaries. This is a result of the approximation introduced in
the histology measurement by assuming ellipsoidal or spherical shape for the tumour,
whereas in MRI the actual tumour shape is obtained in 3D.
Cornelissen et. al. [75] investigated the reliability of MRI tumour volumetry by
comparing it with a water-displacement measurement as a gold standard. The results
confirmed the accuracy and reliability of MRI volumetry.
Most of the MRI studies mentioned above were carried out in vivo. The fact that
MRI measurements of tumour volume can be made in vivo brings a number of advan-
tages when studying animal tumours: In vivo experiments are conducted on the tissue
while its biological function is ongoing, so fewer animals are required compared to end-
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point histology or other ex-vivo volume measurements. That is because the same animal
can be used at different time points in in-vivo MRI whereas only one time point can be
investigated in methods where the animal is sacrificed. However, in-vivo MRI is limited
by anaesthetisation time. According to Benveniste et. al. [59] the anaesthetisation time
for in-vivo MRI of small animals is normally restricted to 4 hours (whereas in-vitro
measurements can be much longer). Also, in-vivo experiments are challenging due to
animal movements as a result of normal breathing and cardiac activity [59].
In order to achieve high accuracy MRI volumetry of rodent brain tumours, high
resolution 3D imaging is required. As the voxel volume decreases, the error in measuring
the volume of irregular tumours decreases. In most of the studies mentioned above,
although a high in-plane resolution was utilised, the slice thickness was larger than 0.5
mm [61, 65, 66, 68, 70, 71, 74]. This level of resolution might be sufficient for the goals
of previous studies where a large variation in volume was expected or a relatively large
rodent was under investigation. In some studies [63,64], the researchers achieved better
3D resolution by using slice thicknesses of 375 µm and 469 µm respectively. The best
resolution (60 × 60 × 60 µm3) was achieved by Holmes et. al. [67] utilising a small-bore
system (30 cm) with a high static field (7T) and a custom-built coil.
In Section (4.2.4), a method for label-free imaging of mouse brain tumours with high
spatial resolution( 125 × 125 × 150 µm3)is demonstrated a using a 1.5 T whole-body
MRI scanner and a commercially available surface coil. To the best of the author’s
knowledge, this is the best resolution that has been achieved to measure mouse brain
tumour volume in a 1.5 T clinical scanner without the use of contrast agents. This
will, first, meet the requirement of the present study for high MRI resolution in order
to facilitate a qualitative comparison with the (far higher resolution) nonlinear optical
microscopy. Second, the image MRI method allowed imaging of 83 mouse brains as part
of a collaborative study with the London School of Pharmacy: tumour volume data was
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compared to maximum diameter estimates, intended to replicate the results of histology
measurements.
High resolution MRI was achieved by utilising a microscopy surface coil (23 mm
diameter, Philips Healthcare) and long imaging times (i.e., averaging over multiple
image acquisitions). The main limitation of time averaging in high resolution imaging is
from movement artefacts. Despite some remarkable work towards minimising movement
artefacts( i.e. [76]) by matching images within a sequence to each other, artefacts can
still be a major obstacle specially when a spatial resolution on the order of 100 µm
is required. Fortunately, movement artefacts were not a problem in the present study
because the mouse-brain samples were fixed in an agarose-gel-formalin mixture which
prevented movement over the imaging period. These measurements, described in Section
(4.2.4), are preceded by some preliminary investigations (Sections (4.2.2) and (4.2.3)).
4.2.2 Whole animal MRI
This section demonstrates MR imaging of a whole animal at sufficient resolution to
allow organ identification. (As mentioned in the introduction, identification of organs
within the animal is required to facilitate drug localisation. If the animal is imaged
before and after nano-medicine administration, enhanced signal will be detected in the
organs where the drug is located.) In this case a euthanised rat was positioned securely
inside an 8-channel RF coil designed for the human head (Philips Healthcare) so as to
prevent movements during the scan. A T1-weighted fast field echo (FFE) sequence with
TR/TE = 50/6.87 ms and spatial resolution of 0.5 × 0.5 × 0.5 mm3 was employed.
The total scan time was 90 min for a 3D field of view of 60 × 180 × 180 mm3. The two
images below (Figure (4.1) and Figure (4.2)) show different coronal slices of the whole
rat. In Figure (4.1) it can be seen that essential organs such as the heart (green arrow)
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can be identified. Similarly, in Figure (4.2) the arrows indicate brain and liver.
For this preparatory study for the mouse imaging, the rat was chosen to be imaged
because of its availability and low cost. The organs of the rat are relatively larger and
and so do not require imaging at such a high resolution. However, the rat was imaged
with a large field of view (FOV) for whole-mouse imaging a smaller FOV can be imaged
at higher resolution within the same total scan time.
2 cm
Figure 4.1: A slice of a 3D MRI image of a whole rat body showing anatomical de-
tails.The arrow indicates the heart.
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2 cm
Figure 4.2: A slice of a 3D MRI image of a whole rat body showing anatomical details.
The arrows indicate brain and liver.
4.2.3 T1 and T2 measurements of mouse brain
It is well established in the literature that T2-weighted imaging sequences provide better
contrast between tumour and normal brain tissue than T1-weighted sequences (e.g. [77]).
In order to achieve high SNR and good image contrast in MRI, the optimum imaging
parameters (TR and TE) should be employed. This optimisation, however, requires
previous knowledge of the intrinsic properties of the tissue of interest such as T1 and T2
values. Although T1 and T2 values for rodent tissues have been published in the MRI
literature, there are a number of practical details that might affect their values in the
present context, such as the formalin fixation protocol, time from animal sacrifice and
tissue handling. In this section T1 and T2 measurements of normal and diseased tissue
will be described.
A formalin-fixed mouse brain was mechanically fixed in 0.5% w/w agarose gel within
a glass container and prepared for MRI scanning. The brain was close to the container
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base inside the gel and, hence close to the surface coil which was positioned under
the container, to ensure the highest possible SNR. The position of the brain was de-
termined using survey sequences (a fast T1-weighted spin-echo sequence followed by a
low-resolution T2-weighted spin-echo sequence) in order to locate the largest tumour
slice. At this stage there was no interest in high-resolution detection of tumour edges,
the surveys were intended to find a suitable slice for T1 and T2 measurements containing
both normal and diseased tissues.
In order to map T1 values an inversion recovery sequence was applied with inversion
times of 50, 100, 200, 500, 1000, 1500 and 2000 ms. For accurate T1 measurements,
the repetition time was chosen (104 ms) to be much larger than the expected T1 values
of brain tissue (known to be not more than 103 ms). This is important to allow full
recovery of the net magnetisation vector (NMV) between successive RF excitations [10].
The inversion recovery is described by Equation (2.20).
The outcome of the scanning process is seven images of the brain slice with the
different inversion times mentioned above. The signal intensity of the tumour area
was measure by selecting a region of interest inside the tumour and measuring the
average grey scale value using ImageJ software. Also, in the same manner the signal
intensity was measured for the normal brain tissue around the tumour. Figure 4.3
shows two plots of the inversion recovery data of normal brain tissue and tumour.
The x-axes represents the inversion time (in ms) and the y-axes represents the signal
intensity (in arbitrary units). The markers represent the experimental data and the
lines represents the curve-fit generated by Easyplot software. It is important to mention
that the standard deviations of grey scale values are ignorable when compared to the
difference in signal intensity between the two different types of tissues. The curve-fits
from both plots reveal the constants in Equation (2.20), namely, M0 and T1. However,
we are interested only in T1 values. The measured T1 values of normal tissue and
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tumour were 643 ms and 748 ms, respectively.
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Figure 4.3: T1 values for tumour and normal brain tissue measured with the inversion
recovery method. Signal intensity is in arbitrary units.
Similarly, to measure T2 values a spin-echo sequence was applied to the same slice
with repetition time 3000 ms and echo times 16, 32, 48, .. 112 and 128 ms. The
measured T2 values of normal tissue and tumour (Figure 4.4) were 99.5 ms and 122 ms
respectively.
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Figure 4.4: T2 values for tumour and normal brain tissue measured by varying the echo
time. Signal intensity is in arbitrary units.
Having the T1 and T2 values of both types of tissue we can theoretically study
the contrast between them if a T2-weighted sequence is used. The optimum contrast
means mathematically that the difference between the signal intensity in the tumour
and normal tissue is maximum. The signal intensity of each tissue can be calculated
using Equation (2.5) substituting the T1 and T2 values measured above and choosing
large TR (3000 ms). The difference between signal intensities in the two tissues is given
by
∆I(TE) = ITumour − INormal (4.1)
The plot of Equation(4.1) as a function of TE is shown in Figure 4.5. From the figure
it can be seen that the optimum contrast between normal brain tissue and tumour can
be achieved by setting TE to 110 ms. This optimised value for TE is used in the
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high-resolution MR imaging described in the next section.
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Figure 4.5: The curve shows the theoretical estimation of the contrast (difference in
intensity, in arbitrary units) between normal brain tissue and tumour as a function of
TE. The optimum contrast is achieved when TE = 110 ms.
4.2.4 High resolution MRI of tumour
The main aim of this chapter is to demonstrate the possibility of tumour detection with
label free MRI and CARS. For MRI, as discussed above, the main obstacle for this is the
limitation of SNR. However, utilising a commercially available surface coil, optimising
imaging parameters (as shown in the previous section) and giving the scan time less
priority, this obstacle can be overcome.
As mentioned above, movements of the sample during scanning result in motion
artefacts. If the magnitude of movement during the scan time of an individual slice
is much smaller than the voxel size, less movement artefacts are detected. However,
in the high resolution MRI scheme adapted in this study, the imaging time has not
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been restricted and the voxel size is relatively very small( 125 × 125 × 150 µm3). This
implies that even very minor movements can significantly affect the image quality. For
this reason, all the brain samples were embedded in 0.5% w/w agarose gel as preparation
for MRI. Another advantage of using agarose gel when using it to mechanically fix the
brain is that it facilitates image segmentation to determine the brain edges.
As mentioned in the previous section the parameters for imaging should be opti-
mised, and using a T2-weighted spin-echo sequence with TR = 3000 ms and TE =
110 ms provides the highest image contrast between normal brain tissue and tumour.
Although the optimisation was based on T1 and T2 measurements of only one brain
sample, it was found that these imaging parameters allowed identification of tumour
edges for all the brains investigated. All brains were subject to similar animal and sam-
ple handling procedures and, most importantly, similar formalin fixation protocols and
times between animal sacrifice and MR imaging.
A particular advantage of conducting MRI experiments ex-vivo is the possibility of
using long imaging times. However, with the large number of brains involved a number
of steps were carried out to maintain the imaging costs of the study within a reasonable
limit. Unlike in-vivo scanning, where the researcher should monitor the experiment as
part of the animal handling procedures, ex-vivo imaging can be carried out overnight
without continuous monitoring. To be efficient in using out-of-hours scanner time, two
brains were imaged simultaneously in each overnight scan. In order to ensure the images
were assigned to the correct brains, the two brains were embedded in the gel in different
orientations close to the container base. Moreover, the FOV of the high resolution
MR image was kept as small as possible. This was achieved by utilising a fast 3D
survey image to determine roughly the location of the tumour (fast field echo (FFE)
T1-weighted sequence, TR/TE = 57/21 ms, typical matrix dimensions 148 × 97, slice
thickness 0.6 mm, interslice gap -0.3 mm). Using this fast survey sequence, a 3D FOV
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that includes the two brains ( 9 × 30 × 30 mm3) could be imaged in 76.3 s. Figure (4.6,
a) shows a slice of a typical 3DFFE survey where the two arrows indicate the tumours.
After locating the tumour with the survey, a high-resolution T2-weighted sequence
with the optimised parameters was applied (in-plane resolution 125 × 150 µm2 and
slice thickness 150 µm). Figure 4.6(b) shows the high-resolution image of the tumours
in the two brains shown in Figure 4.6(a). In the high-resolution image the FOV is
minimised as much as possible, to include the two tumours. This is done by reference to
the survey image, as shown in Figure 4.6(a), where the new FOV is determined by the
yellow rectangle. In this case the new FOV of the high resolution T2-weighted image is
10.05 × 18 × 5.8 mm3. Using 10 signal averages, the total scan time is 4.28 hours, i.e.,
around two hours per brain.
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Figure 4.6: (a) T1 weighted Low-resolution survey image of two typical brains embedded
in agarose gel. The arrows show the tumour locations. The yellow rectangle shows the
selected new FOV, as in (b).
(b) High-resolution T2-weighted image of two brains with FOV positioned around the
tumours. The grey scale profile of the yellow line drawn across the lower tumour is
plotted in Fig.4.7.
It can be seen that the tumour edges are much clearer in the optimised image
in Figure 4.6(b) than in the survey image in Figure4.6(a). Figure4.7 shows a signal
intensity profile for a line drawn across one of the tumours in the high-resolution image
(the yellow line in Figure4.6(b)). The sudden change of grey scale value at the edges
of the tumour is easily seen. Although there are other areas in the overall image that
have a similar signal intensity to the tumorous tissue, with some knowledge of normal
brain anatomy the tumours can be easily identified.
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Figure 4.7: A plot of grey scale line profile across the tumour. The profile is for the
yellow line in Fig 4.6(b). Signal intensity is in arbitrary units.
4.2.5 MR image processing
Having acquired a 3D stack of high-resolution images the tumour volume can be cal-
culated with image processing. Previous studies have worked towards automated seg-
mentation of brain tumours, but this is still challenging due to the brain’s complicated
anatomy. Even for the human brain, which is obviously much larger than a mouse brain,
a recent article suggests semi-automatic rather than automated segmentation [78]. For
mouse brains, a number of studies have adopted full manual processing by determina-
tion of the tumour area in each slice [63, 64, 71, 74]. The methods used in the present
study for tumour boundary detection, tumour volume measurements and 3D tumour
shape visualisation are described below.
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MR Image normalisation
In typical MRI scanning the grey scale values of different slices are automatically nor-
malised against the unavoidable signal intensity variation caused by the receiver coil
geometry. For example, the signal detected by a surface coil varies as a function of the
distance between the voxel source and the centre of the coil. For similar tissues, grey
scale values from unnormalised slices close to the coil are higher than those at larger
distance.
For the high-resolution sequence used for this study the automatic normalisation
function (’Clear’) provided by the Philips scanner did not work due to unknown tech-
nical problem. Both manual and automated segmentation are easier to carry out on
normalised images, where equivalent slices have similar ranges of grey scale. For this
reason, individual (slice) images were normalised against the distance from the surface
coil by dividing each image by its mean grey scale value using an ImageJ macro that
was developed for this purpose (Appendix.1). Fig.4.8 shows an example of two tumour
slices at different distances from the coil, before and after normalisation (sample ref-
erence MRI3-83). The left-hand images are normalised and the right-hand images are
unnormalised; images (a) are closer to the coil than images (b). It can be seen that,
in the two normalised images, the brain anatomy details are observable (with clear tu-
mour boundaries) without changing the image brightness or contrast. Whereas in the
unnormalised images, if the brightness and contrast are left unchanged, only image (a)
has clear details. This suggests that the normalised data set is appropriate for further
image segmentation and processing, but the unnormalised data set is not.
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Figure 4.8: Images of two slices at different distance from the surface coil. The lefthand
images are normalised and the right-hand images are unnormalised. The (a) images are
closer to the coil than the (b) images.
Tumour volume measurements
All the images were obtained from the scanner and normalised against distance from
coil with ImageJ as described in the previous section. To measure tumour volume,
manual image processing was carried out using Osirix software installed on a MacBook
Pro computer with OS X Lion (10.7) operating system. When opening the image in
Osirix the 3D resolution of the image is checked to correspond to the known image
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details. Then, using the available region of interest (ROI) tools, the tumour is manually
determined as a region of interest in the image slice. Fig.4.9 illustrates three typical
images of slices from different brains (sample references MRI3- 66, 70, 72) showing the
slices before and after selecting the ROI. The images show clear tumour edges even
when the signal intensity from tumour is similar to some areas in normal tissue.
After having selected the ROI slice by slice for the whole tumour, all the ROIs in
the 3D data set are merged to a single ROI, whose volume is computed using the ROI
volume command. The Osirix software computes the volume from the total number of
voxels and the known resolution of the image.
The volumes of 83 mouse brain tumours were calculated using the MRI based meth-
ods explained above. Results are detailed in Appendix..2. The brains in the tables had
been subjected to three different types of anti-cancer medications by our collaborators
from the London School of Pharmacy.
One of the clear properties of brain tumours is that they do not form a spherical
shape. Fig.4.10 shows a 3D model, generated by using Simpleware software with thresh-
old segmentation and manual finishing, of an example tumour illustrating its irregular
shape. An analysis of the effect of this irregularity in the tumour shape on conventional
histology volumetry will be presented in the next section.
88
Chapter 4. Label-free Imaging of Tumours
Raw images ROI selected  
images
2.5 mm2.5 mm
2.5 mm2.5 mm
2.5 mm2.5 mm
Figure 4.9: Three example images from different brains before and after ROI selection.
Raw images are on the left and images with ROI selected are on the right.
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5 mm
Figure 4.10: 3D model of a tumour showing its irregular shape. The model was gener-
ated with Simpleware software using semi-automated segmentation.
MRI vs semi-histology volumetry
The high-resolution label-free MRI of tumours presented in this chapter has allowed
detection of well defined tumour edges and determination of tumour volumes. From a
theoretical perspective, as explained in section(4.2.1), the high-resolution images should
provide volume measurements with high accuracy. A number of studies have compared
MRI volumetry to histology, assuming histology as the gold standard [66, 68, 70, 73].
However, in this section, MRI (3D ROI) is chosen to be the gold standard to which
volume histology is compared. In fact, MRI volumetry is not here compared to true
histology volumetry, but instead compared to simulated histology, using measurements
from MRI image slices (see below) to mimic measurements from histology. The study is
intended to provide some evidence of the effect of tumour shape on volume measurement.
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As discussed in Section(4.2.1), histology is regularly used to measure tumour volume
in mouse brains. The process is done by slicing the mouse brain in a coronal orienta-
tion, followed by choosing the largest tumour slice. The largest and smallest tumour
diameters within this slice are determined, and an average diameter d is calculated,
from which the tumour volume V is calculate using the formula V = pi d3/6 (i.e., as
for a sphere of diameter d). In the present study this histology volumetry is simulated
by making equivalent measurements on coronal slices from the 3D MRI data set. Two
diameters (major and minor) are measured using Osirix as illustrated in Fig.4.11.
2.5 mm
Figure 4.11: Tumour diameter measurements from a coronal cross- section of mouse
brain, simulating histology measurements.
The volumes of all the tumours were measured with this simulated histology method
(Appendix .2). In order to compare the outcome of both methods, MRI (3D ROI) and
simulated histology, the two data sets have been used to generate the scatter plot in
Fig.4.12. The horizontal axis is the tumour volume measured with MRI (3D ROI) and
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the vertical axis is the tumour volume measured by simulated histology. If the two
methods had perfect agreement, the data should fit exactly on a straight line through
the origin, with unity gradient. However, it can be seen that in practice the data points
are scattered around this line. Although the agreement looks satisfying, there are some
significant discrepancies when considering individual differences. The differences as a
percentage can be calculated using Equation ((4.2))
∆V% =
VMRI − Vsim−Histology
VMRI
× 100 (4.2)
The percentage differences calculated from Equation(4.2) are plotted in Fig.4.13,
with the sample number on the horizontal axis. Perfect agreement would give 0%
differences. However, it is obvious that the data points are scattered with percentage
differences up to 60%. The average percentage difference (magnitude) is found to be
20%, which is considerable. This discrepancy, as discussed before, derives from the
spherical shape assumption used in histology volumetry.
It is suggested that MRI can be considered as a potentially more accurate alterna-
tive to histology when measuring the volume of mouse brain tumour for longitudinal
pharmacological studies. Because of the suggested unreliability of the histology method,
it may well be that using this method requires more animals to be sacrificed in order to
obtain statistically significant results, so the MRI method may be preferable from an
ethical perspective.
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Figure 4.12: A plot of MRI (3D ROI) volume measurements vs simulated-histology
measurements for 64 mouse brain tumours. The straight line indicates perfect agree-
ment.
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Figure 4.13: Percentage difference between MRI (3D ROI) volume measurements and
simulated-histology measurements for 64 mouse brain tumours, plotted against sample
number. The horizontal line represents perfect agreement (∆V% = 0).
4.3 Nonlinear optical microscopy of mouse brain tu-
mour
4.3.1 Introduction
As mention in Chapter.1, for this study, Coherent Raman Scattering CRS is more attrac-
tive as a microscopy modality than the conventional fluorescence confocal microscopy
due its label free nature. In CRS the unlabelled tissue is imaged via the abundance
of CH bonds in its biological membranes. For pharmacological studies, when using
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nanoparticles as carriers and/or tracking markers for anti-cancer drugs, it is desirable
to keep the biological system as normal as possible. CRS is able to show 3D images with
sub micron resolution showing cells and their nuclei, blood vessels and red blood cells.
Moreover, another particular advantage of using CRS against confocal fluorescent mi-
croscopy is its high contrast when imaging brain tissue to distinguish the type of tissue.
This is applicable for the different shape and orientation of the micro structure of lipids
and myeline and CH bond concentration. In case of nanoparticles contrast delivery, it is
valuable if one is able to assign the particle distribution within this level of details of the
biological context. Moreover, the laser sources used for CRS can generate the linear and
nonlinear optical contrast from the proposed nanoparticles and also excite two-photon
photo-thermal lensing(TPPL) of red blood cells which is an important technique that
provides a 3D map of brain tissue vasculature. This technique is desirable to assign the
distribution of nanoparticles as distance from blood vessels.
As a part of the technique development in this section CRS imaging of normal brain
tissue and tumour will be presented. Also, acquiring a ”mosaic” grid of images of brain
slices will be demonstrated for a qualitative comparison with MRI.
4.3.2 CARS imaging of tumour
Imaging brain slices with CARS can be carried out with the two available optical setups
mentioned in section(3.3.3). Both setups can generate forward and backward signals
that can be detected and reconstructed into images with a desktop computer. However,
it is very important to determine the optimum imaging choice depending on the tissue
optical properties and sample thickness. Brain tissue in known to be highly scattering
due to its non-uniform refractive index and relatively thick (0.5 mm) brain slices where
used to avoid sample damage. Accordingly, it was found that forward detection setup
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can yield low quality images comparing to the epi-CARS images which benefited from
the strongly back-scattered F-CARS signal. For this reason a combination of 816.4 nm
from the OPO as pump and the 1064 nm as Stokes was adopted to generate anti-Stokes
signal at 660 nm to increase back scattered signal. Figure(4.14) shows an example of
detailed epi-CARS image of mouse brain tissue obtained using this setup.
One of the main aims of this chapter is to find a method to qualitatively compare
images acquired with MRI and CARS. This is made challenging by the different reso-
lution and field of view (FOV) of the two modalities. The high resolution MR images
of mouse brain presented in Figure (4.6(b)) are of in-plane resolution of 125 µm and
a slice thickness of 150 µm with a FOV is capable of covering the whole brain in one
3D image. In contrast, the in-plane resolution of CARS images is 250 nm and the slice
thickness is 1 µm with a FOV of 250 µm when using a 60× lens. If a 20× lens is used,
the in-plane resolution is 750 nm with a FOV of 750 µm.
In order to overcome the FOV limitation in CARS images, the mosaic grid of images
is adopted. The mosaic imaging was reported by Fu and coworkers as a powerful method
to map brain structures over a large FOV with high spatial resolution [79]. In their work,
mapping nerve fibres of the brain was ideal for imaging the anatomical structures where
fine biological details were not important. However, in this study, it is very important to
acquire high resolution images to reveal the fine detailed structure to compare a feature
from the MR image and cellular location of a nanoparticle.
In this mosaic technique, the motorised stage (Prior, Proscan) is programmed and
synchronised with the microscope to acquire images at different ( x , y ) coordinate
positions. The coordinates of the images are in a grid built as an Excel file, converted
into comma separated values(csv) format and uploaded to the motorised stage soft-
ware according to a previous estimation of the brain slice dimensions. Another table
containing the imaging parameters such as photomultiplier tube (PMT) voltage, gain,
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scan speed, zoom and image dimensions is uploaded to the microscope software. The
track number and the coordinate file name in the xy-stage file should match those in
the microscope software file. Also, the most important step is to correctly chose the
starting coordinates to match the brain slice location and the PMT voltage that gives
the optimum image quality according to the imaging session parameters such as laser
power and the depth of the imaging plane.
200 µm
Figure 4.14: Detailed CARS image showing the different structures and features of brain
tissue. This is a zoomed-in image determined by the yellow rectangle in the large mosaic
presented in Fig.4.15.
After having acquired the images, the stitching is carried out using ImageJ software
and Plugins ( Stitching - Stitch sequence of grids of images). To use this image stitching
plugin the images should be saved in the form of (Tile zzz yyy xxx) where zzz, yyy and
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xxx are three digits numbers that determine the image as an element in a 3D matrix.
However, in this special case the zzz values are always 001 because there is only one
imaging plane. The xxx and yyy rage from 001 to the maximum number of images in
each of x and y axes.
It is very difficult and time consuming to rename the large number of images required
for the mosaic manually. Accordingly, an ImageJ macro was built to accomplish this
automatically (Appendix.1.2). When running the ImageJ macro the user is asked to
determine two directories of two folders by browsing, the first where the row images
are saved and the other where the Tile images should be saved. Also, the user has to
determine values for the parameters ”ymax” and ”xmax” within the macro that indicate
the y and x dimensions of the grid matrix respectively.
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2.5 mm
Figure 4.15: Large scale mosaic of CARS images of a whole brain slice. The mosaic
is obtained by stitching 750 CARS images acquired by a 20 times objective lens. The
yellow rectangle corresponds to Fig.4.14
There are two major experimental issues that must be taken into consideration when
creating large area scan with CARS. First, the coverslip spacers thickness should match
the brain slice within the two coverslips. Even small difference causes microscopic
curvature of the coverslips from one or both sides. This curvature causes the imaging
plane to be within the biological tissue in one place and in the coverslip in another.
To be able to image a whole slice with such a curvature the imaging plane should be
sufficiently deep into the tissue to prevent the image plane from leaving the brain tissue.
This usually results in a low quality image. Even if a sufficiently deep mosaic image is
obtained, the individual images will correspond to different actual plane of the biological
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tissue because of the curvature. Fig.4.16 illustrates the coverslip curvature effect of the
imaging plane focussing.
Brain slice
 coverslip
spacer
Imaging plane
2.5 mm
Figure 4.16: The effect of coverslip curvature on CARS mosaic images. The green
ellipse determined the in-focus while the rest is out of focus of imaging plane. The
lower sketch is an illustration of the curvature resulting from the thinner coverslips
spacers. The yellow rectangle shows the power of CARS in sharply determining tumour
edges( This image is not intensity normalised).
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Figure 4.17: Image normalisation of CARS mosaic of mouse brain tissue. The unnor-
malised image (left) has unwanted dark sides of individual images. Each individual
image was divided by an averaged FWM image of glass coverslip surface to generate
the uniform intensity normalised mosaic (right).
The second experimental obstacle toward high quality mosaic CARS imaging arises
from the geometry of the objective lens combined with the scanning nature of multi-
photon microscopy. The intensity of a CARS image follow a Gaussian profile resulting
in lower signal in the image periphery. This Gaussian profile is due to what is con-
ventionally known as phase curvature. CARS based originally on two laser beams that
geometrically setup to satisfy phase matching condition ( an important condition to
generate CARS, see Section(2.3.5)) [41]. To satisfy this condition for microscopy, two
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collinear beams are focused with a high numerical aperture lens [42]. However, when
scanning the beams over the field of view, the beams deflect larger angles to excite points
in the image periphery and spherical aberration degrades the phase matching. This issue
was tackled during the experiment by optimising imaging setup and after experiment
by postacquisition image processing. During this experiment a 20 times lens was used
to minimise this effect. Also, 2× zoom was used in the microscope software to limit the
scan to the most uniform area ( 475.5 × 475.5 µm2). Post image processing normalised
the image intensity by dividing each image in the mosaic by an average image of the
non-resonance signal from the coverslip. However, dealing with a such large number
of images manually is time consuming. for this reason, an ImageJ macro was built to
carry out the process automatically. Figure (4.17) illustrates the image normalisation
process showing a mosaic image of a mouse brain before and after normalisation. The
intensity of each individual image in the unnormalised mosaic (left) is dimmer at the
edges of each tile, which results in unwanted artefacts. However, after normalisation
of the mosaic image (right) this effect is almost unnoticeable. The small image in the
centre is the averaged non-resonance CARS image of a glass coverslip surface that each
individual image is normalised by.
4.4 Summery
In this chapter, the label-free imaging of mouse brain tumour using MRI and CARS
was explored. The main aim was to investigate the capability of both techniques in
detecting tumour with a distinguishable contrast between healthy and diseased tissues.
To achieve this goal for MRI, preliminarily experiments were conducted to optimise
the MR imaging sequences and parameters. A 1.5 T clinical MRI scanner was used
with a micro surface coil to achieve a high spatial resolution (125 × 125 × 150 µm3)
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within a reasonable imaging time ( 2 hours per brain). The data was used to measure
tumour volume using Osirix software after a manual slice-by-slice tumour boundaries
determination by the user. Moreover, the data was used to simulate the conventional
histology measurements of mouse brain tumour by choosing the largest coronal tumour
slice, measuring its diameter, and calculating the tumour volume assuming a spherical
shape. The 3D MR images were also used to simulate histological volumetry. The two
sets of data were compared and it was found that histology volumetry suffers from an
average of 20% error as a result of irregular tumour shape. This suggests that MRI is
a powerful alternative and requires less number of animals when compared to histology
to achieve significant statistics which is an important finding from ethical point of view.
A CARS microscope with 1064 nm and 816 nm laser excitations combination was
used to image mouse brain tumour. It was found that sharp contrast between healthy
tissue and tumour is achievable when imaging in the backward direction benefiting from
the scattering nature of the brain and the relatively short wavelength anti-Stokes CARS
signal generated by the laser excitations mentioned above. The FOV limitation of CARS
images which disallows comparing with MR images was tackled via proposing mosaic
of images that covers a whole brain slice. Moreover, image processing technique was
developed to compensate for the phase curvature in the CARS images.
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Chapter 5
Nanoparticle characterisation
5.1 Introduction
The biomedical applications of nanoparticles are currently of great interest and there
has been remarkable efforts toward fabricating and characterising their magnetic and
optical properties. The paramagnetic property is of interest to be able to use particles as
MRI contrast agents and the optical properties are desirable for light microscopy. Iron
oxide and gadolinium oxide nanoparticles are well stablished as MRI contrast agents
[80]. It has been reported that their longitudinal and transverse relaxivities are higher
than the clinically used gadolinium complexes because of the condensed nature of the
particles [81,82].
This chapter describes the characterisation of the particles used in this thesis. The
characterisation includes investigation of the shape and particle size, crystalline struc-
ture, optical properties and MR relaxivity. A novel technique is presented to measure
particles photoluminescence (PL) properties using a Raman microspectrometer over an
extended spectral range. Also, to the best of the author’s knowledge, upconversion pho-
toluminescence (UCPL) of doped Gd2O3 is investigated under a focused pulsed laser
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excitation for the first time.
5.2 Composition materials
Table(5.1) shows the gadolinium oxide nanoparticles (GONPs) samples that were fab-
ricated and investigated throughout this study. The particles were doped or co-doped
with different lanthanide ions in different molar percentages for different investigation
purposes which will be illustrated later in this chapter and in the next chapter.
Although the chemical reaction in the precipitation method adopted in this study
was reported by Hemmer et. al. [57], it is important to know the composition materials
in order to ensure that right nanoparticles with the doping elements have been made. For
this purpose, energy dispersed X-ray spectroscopy (EDS) has been employed. Fig.5.1
is an SEM image of GONPs doped with 5% Er3+. Three dispersive energy spectra
were acquired on three relatively large scale regions for the sake of significant averag-
ing. In order to illustrate the patterns of the obtained spectra, an example spectrum
(spectrum1) is shown in Figure (5.2). As illustrated in Table(5.2) all three spectra were
analysed automatically with a fitting software into weight percentages. It is important
to mention that there are two obstacles towards accurate quantitative EDS. Firstly,
having the particles in oxides form. Oxygen is light element that possesses relatively
low energy characteristic X-ray with a very low quantum yield. Also, even if a sensitive
detector is used this low energy X-ray is more probable to be absorbed by the material
itself with low portion escaping the sample surface to reach the detector. The second
practical difficulty toward quantitative EDS is having the material in particle form.
Relatively large, flat and polished surfaces are required to achieve accurate quantitative
analysis [83].
However, it is still valuable for this study to employ EDS in order to obtain quali-
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Table 5.1: Lanthanide doping percentages of Gd2O3 nanoparticles
Sample
Doping percentage (mol%)
Yb3+ Er3+ Tm3+
S1 1 1 0
S2 20 5 0
S3a 0 5 0
S3b 5 0 0
22 0 0.5 0
23a 0.5 0 0
24 10 0 2
29 10 0 4
30 0 5 2
31 10 0 1
32 10 0 0.5
tative data to confirm the degree of doping which is vital for the optical properties. In
Table(5.2) we can ignore the carbon percentage because it is the composition martial
of the conductive tape. The qualitative data in the spectra and the table prove the
existence of the doping element ion Er3+ within the particle material (Sample 3a). EDS
of sample 3a was presented in this section as an example.
This section confirms that the fabricated gadolinium oxide particles were successfully
doped/co-doped with the lanthanide ions. This is necessary for the particles to possess
the optical properties required for optical microscopy.
106
Chapter 5. Nanoparticle characterisation
! Spectrum1
Spectrum2
Spectrum3
Figure 5.1: SEM image of Gd2O3: 5% Er
3+ nanoparticles with three rectangles indi-
cating three areas where the three EDS spectra in Table(5.2) were acquired.
keV
Figure 5.2: The dispersive energy spectroscopy of of Gd2O3: 5% Er
3+ nanoparticles.
The spectrum corresponds to the upper rectangle labeled (spectrum1) in Fig.5.1.
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Table 5.2: The EDS data of Gd2O3: 5% Er
3+ nanoparticles. The three spectra in the
table correspond to the three rectangular areas in Fig.5.1. All results are in weight%.
Spectrum In stats. C O Gd Er Total
Spectrum 1 Yes 21.24 15.99 58.64 4.13 100.00
Spectrum 2 Yes 22.70 15.42 58.07 3.81 100.00
Spectrum 3 Yes 19.44 15.35 60.82 4.39 100.00
Mean 21.13 15.59 59.18 4.11 100.00
Std. deviation 1.63 0.35 1.45 0.29
Max. 22.70 15.99 60.82 4.39
Min. 19.44 15.35 58.07 3.81
5.3 Morphology and size
The morphology and size of the nanoparticles are important factors when using them
for MR and CARS imaging contrast. Moreover, the monodispersity of the particle
size is significantly important in the case of targeted drug delivery where the same
pathway within the body is desirable [84]. For instance, nanoparticles of the same size
are expected to diffuse into the tumour in the same manner whereas particles with a
different size would be expected to behave differently. Accordingly, size and morphology
of nanoparticles were inspected before they were used experimentally.
Scanning Electron Microscope (SEM) and Transmission Electron microscope were
utilised for this purpose. However, for SEM imaging, because the doped GONPs are
semiconductors with a wide band gap (5.2 eV) [85], they have been spread on a con-
ductive carbon tape to eliminate any electrical charging of particles that may result in
unwanted artefacts and hence low quality image. In Figure (5.3) two example SEM
images of doped Gd2O3 particles (Sample1) are presented. In image (a) the single par-
ticle size ( diameter = 257.7 nm) is determined with the size tool available in the SEM
software. To show the monodispersity of the particles, larger field of view (FOV) image
was acquired for the same sample(image b).
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a         b
Figure 5.3: SEM image of doped Gd2O3 nanoparticles (Sample1). Image (a) shows the
spherical particle shape with diameter of about 260 nm) whereas image (b) is a large
scale image that shows the size monodispersity of the particles.
Because these particles are proposed to be used as biomedicine contrast agents,
controlling their size is desirable for medical investigation purpose as mentioned above.
Hemmer et. al. have utilised surfactants to obtain different sizes of doped Gd2O3
nanoparticles [57]. However, in this study a simpler approach for controlling size was
achieved by changing the nucleation time of the particles. Figure (5.4) shows two images
of doped gadolinium oxides particles of different sizes. The nucleation time was 30 min
for the particles in image (a) resulting in particle size of (230 - 265 nm). Only by
changing the nucleation time to 15 min, the particle size could been reduced to 85 nm.
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a b
Figure 5.4: SEM image of doped Gd2O3 nanoparticles. Image (a) shows particles with
size of (230-265 nm) obtained with 30 min nucleation time. Image (b) corresponds to
85 nm particles fabricated with 15 min nucleation time.
In order to estimate the monodispersity of the particles statistically, they were first
distributed uniformly in 2D on a glass coverslip. This was achieved by washing the
glass with soap and water, then cleaning with acetone and followed by rinsing with
propanol. Nanoparticles suspension was prepared by adding 0.5 mg of the particle
powder to 1 mL propanol then sonicating for 30 minutes. A droplet of the suspension
was then spin coated onto the coverslips. It was found that a rotation speed of 200
revolutions/min was optimum for this purpose. Slides were then coated with a 3 nm
gold film in order to overcome the charging artefacts caused by their large gap instead
of placing them on carbon tape. Fig.5.5 (a) is an SEM image of 2D distributed doped
gadolinium particles. In image (b) the particles where selected by brightness threshold
using ImageJ followed by particle size analysing using the ”Analyse Particles” plugin.
The largest feature included in the analysis was limited to 10 pixels, to avoid inclusion
of particle aggregations (c). Finally, the particles selected and analysed are presented by
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small circles in image (d). The sizes of the particles was measured by assigning the area
in pixels to the actual image dimensions assuming circular appearance of particles in the
image. The size distribution histogram is plotted in Fig.5.6. The same procedure was
executed to statistically inspect the size distribution of iron oxide particles fabricated by
the hydrothermal method (S21). The particles form in cubic shape, and, accordingly,
they appear as squares in the SEM image. Therefore, side length is measured and cubic
volume is considered. The result is shown in Fig.5.7.
In both size distribution histograms it is obvious that both fabrication methods
produce particles with a good degree of monodispersity for this preliminary study ( the
particles were not injected to live animals throughout the study) . Moreover, adding
surfactants potentially enhances the size monodispersity as reported in the literature
(e.g. [86] and [87]). It can be concluded from this section that the two fabrication
methods adopted in this study are capable of producing monodispersed nanoparticles
applicable for biomedical investigations. Moreover, the particle size is easily tuneable
in both methods either by changing nucleation time in the homogeneous precipitation
method or by changing the starting solution concentration in the hydrothermal method.
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a) b)
c) d)
Figure 5.5: An illustration of the process of the statistical analysis of particle size
monodispersity. The SEM image (a) was intensity threshold to select particles (b).
Image (c) shows the parameters chosen in ”Analyse Particles” ImageJ plugin, and (d)
shows the selected particles.
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Figure 5.6: Histogram of size distribution of doped gadolinium oxide nanoparticles
(S3a). The x-axis represents particle diameter obtained from the circular appearance of
the particle in the SEM image in (nm)
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Figure 5.7: Histogram of size distribution of Iron oxides nanoparticles (S21). The
rectangular particle appearance in the image is assumed to be square and hence the
side length is considered in (nm)
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5.4 Crystalline structure
The crystalline structure of doped gadolinium oxide nanoparticles is vital for photo-
luminescence (PL) and upconversion photoluminescence (UCPL) [88]. For this reason
the crystalline phase of the doped gadolinium particles was inspected before and af-
ter annealing at 950◦ for 30 min using an X-ray diffractometer (XRD). The process
of diffraction was carried out with what is conventionally known as powder diffraction
setup. A powder of a material oriented randomly in all possible directions is equivalent
to rotating a single crystal in all possible angles in front of an X-ray beam. However, an
ideal powder with small enough particle size and complete randomness with no prefer-
able direction is required to reach statistically significant pattern. These conditions are
satisfied with the nanoparticles under investigation where the size is relatively small
and no known factor acts on the particles externally to alter the orientation degree of
freedom. In Figure(5.8) it can be seen that the XRD pattern before and after annealing
is completely different. The annealed particles powder possesses strong peaks which
indicates that they are in the crystalline form. Moreover, the detected XRD pattern
matches that reported by Chen and coworkers an erbium doped gadolinium oxide crys-
tals [89]. Also, the pattern matches the JCPDS database entry for the same material.
For the sake of reducing the cost of the XRD characterisation process, only one patch
of the early-fabricated particles was investigated. However, there are two reasons to be
confident that the other particles would develop the same crystalline structure. Firstly,
all the doped gadolinium oxide particles were fabricated with the same homogenous
method. Moreover, the same starting chemical compound groups (Nitrates) of different
lanthanide ions were utilised. Secondly, possessing strong photoluminescence properties
is another indication of the crystalline phase as illustrated in more detail in the following
section.
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Figure 5.8: XRD of doped gadolinium particles (sample 3a) (a) as prepared and (b)
annealed at 950◦ for 30 min. The pattern matches XRD of Er doped gadolinium oxide
(C) as reported in reference [89].
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5.5 Photoluminescence
Photoluminescence of rare-earth-ion doped organic and inorganic materials has been
investigated in a number of previous studies [90,91]. Among those materials, magnetic
nanoparticles are attractive for the multi-modal imaging capability. Doped Gadolin-
ium oxide in particular received noticeable attention for their high relaxivity in MRI
compared to the clinically used complexes.
Photoluminescence properties of doped gadolinium oxides particles are interesting
for medical imaging. Before imaging these particles, it is necessary to characterise their
photoluminescence with a spectroscopic setup for several reasons. First, some of the
important material structural properties such as crystallite can be inspected. As men-
tioned in section 5.5, XRD was carried out for only one sample and photoluminescence
strength depends on the crystalline structure (an experimental evidence is given be-
low). Secondly, photoluminescence is a fingerprint of the dopant ions. Using this finger-
print signature, the doping of gadolinium oxide crystals can be confirmed qualitatively.
Thirdly, the strength of photoluminescence is an indication of the efficiency of using
these particles for imaging purposes where strong signal results in acceptable imaging
averaging. Finally, although the mechanism of upconversion photoluminescence is com-
pletely different from photoluminescence, particles with strong photoluminescence pose
efficient upconversion photoluminescence. For these reasons, the photoluminescence
spectroscopy for doped gadolinium oxide was performed.
The process in which photoluminescence occurs in lanthanide doped gadolinium ox-
ide nanoparticles is explained in section (2.3.9). In summary, a visible or ultraviolet
photon is absorbed by the material and a lower energy photon is emitted at the char-
acteristic wavelength. In a typical photoluminescence spectroscopy measurement an
ultraviolet excitation is utilised (as examples see references [92–94]). This is to generate
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emissions from all the possible energy levels in the visible and infrared regions because
only levels with energies lower than the excitation photon are emitted. In this study,
a commercial compact Raman spectrometer equipped with 532nm green and 785 nm
infrared lasers was used. The limitation of using such excitation lasers is the inability
to detect any emission with wavelength shorter than 535 nm. Also, there is another
limitation in the detection spectrum range of the microscope for the diffraction gratings
and the detector arrangements. When using the 532 nm laser, the maximum detectable
wavelength is 750 nm and it is 1050 nm when utilising the 785 nm infrared laser. These
detection ranges are enough to detect the photon energy shift caused by the relatively
low energy Raman shift from molecular vibrations. However, for photoluminescence
spectroscopy, the detection range is desired to be large to detect all the possible peaks
which include the visible and infrared part of the spectrum.
Nevertheless, despite limitations with the Raman spectrometer it was found to be
acceptable for the purposes of this study. Firstly, there is more interest in the rela-
tively longer wavelength for biological imaging application. Short wavelengths are more
scattered in the biological tissue which results in low quality image and short imaging
depth. Accordingly, it is sufficient to investigate peaks longer than 532 nm. Moreover,
any missed short peak will be investigated in the upconversion photoluminescence spec-
troscopy in the following section. Secondly, regarding the spectrum range, having two
excitation lasers (532 nm and 785 nm) allow for full spectrum detection in two separate
acquisitions.
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Figure 5.9: PL spectrum of different percentages doped/co-doped gadolinium oxide
particles excited with a 532 nm green laser. The figure shows the effect of varying the
doping percentages on the ratio of red/green photoluminescence.
There are three different doping rare earth ions investigated in this study: ytterbium
(Yb), erbium (Er) and thulium (Tm). Doping Gd2O3 with each element generates a
band of emissions with a specific pattern that corresponds to the energy levels created
within the relatively large band gap crystal. Figure (5.9) shows photoluminescence
spectra of three samples ( S1, S2, and S3a) under 532 nm excitation with a 1 mW
power and 5x lens. The three samples are either doped or co-doped with ytterbium and
erbium in different percentages as mentioned in Table(5.1). All the peaks in this range
of wavelengths corresponds to the transitions in the Er ions. The red photoluminescence
is generated via the transitions between 4F9/2 and
4I15/2 whereas the green results from
the emissions from 4S3/2 and
2H11/2 to
4I15/2 [95]. It can be seen from the same figure
that the ratio of the red/green emissions is tuneable by changing the percentages of the
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doping ions.
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Figure 5.10: PL spectrum of gadolinium oxide particles (S1, S30, and S31) excited with
785 nm CW laser.
As mentioned before, when using the 532 nm green laser the maximum detectable
wavelength is limited to about 750 nm. Accordingly, the infrared 785 nm laser was
used to detect longer-wavelength peaks. Figure(5.10) shows the resulting spectrum of
S1(1% Yb, 1% Er), S30(5% Er, 2% Tm) and S31(10% Yb, 1% Tm) indicated with
the different colours in the legends. Before any further discussion and analysis it is
important to mention that the different spectra are normalised to put them in the same
figure.
There are strong bands of emissions at the ranges (790 - 850 nm) and (950 - 1040
nm). The peaks of the blue and green lines spectrum at 811 nm are due to the transitions
from 3H4 to
3H6 that is generated by the Tm ions [96]. The peaks in the other range
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(950 - 1040 nm) are either from the 2F5/2-
2F7/2 transitions in Yb ions or
4I11/2-
4I15/2 in
the Er ions. The Yb emission at 978 nm has also a strong absorption cross section that
has been utilised to generate efficient upconversion photoluminescence (see the following
section). One of the attracting observation of this spectrum is the relatively stronger
811 nm illuminated from Tm ions comparing to the Yb 978 nm emission. This can be
confirmed from the spectrum of S31.
To confirm that photoluminescence is a finger print of doping element, a closeup look
at the range (950-1040 nm) is taken (Fig.5.11). The spectra were taken under different
excitation powers, objective lenses and focus situations to avoid detector saturation,
therefore, the intensities were normalised to allow qualitative comparisons and analysis.
In Fig.5.11 (a) and (b) Tm ions do not have active transitions in this range which
suggest that the peaks correspond to Er and Yb ions. The addition of spectra (a) and
(b) is presented in Figure (5.11 (c)). The resultant pattern is similar to the spectrum of
a third sample containing the two types of ions Fig.5.11(d), indicating that the doping
of a specific ion can be confirmed from the spectra pattern even if the hosting crystal
is doped with several ions.
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Figure 5.11: PL spectrum of gadolinium oxide particles under 785 nm CW laser excita-
tion, a) doped with Er and Tm and the peaks correspond to the 4I11/2-
4I15/2 transitions
in the Er ions. b) doped with Yb and Tm and the peaks correspond to the 2F5/2-
2F7/2
transitions in Yb ions. c) is the addition of (a and b). d) doped with Yb and Er.
In order to emphasise the importance of the annealing process which provide the
particles with the crystalline form, a photoluminescence spectrum was acquired for S2
before and after annealing (Figure (5.12)). It is obvious that flat spectrum with no
sharp peaks results from the un-annealed particles whereas strong emissions detected
from the annealed particles, hence confirming the crystalline structure of the annealed
particles.
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Figure 5.12: PL spectrum of doped gadolinium oxide particles(Sample2) as prepared
(red) and annealed at 950◦ for 30min (blue). The figure demonstrates the importance
of annealing for optimum optical properties.
5.6 Upconversion Photoluminescence Spectroscopy
Upconversion photoluminescence is an attractive optical property of crystals doped
with optically active rare earth ions, which offers several novel advantages. Firstly,
upcoversion emission is relatively strong and proved to be efficient for imaging even
with a CW laser if tuned to the Yb absorption band at 980 nm [57, 97, 98]. Secondly,
the emissions peaks are sharp and well defined with multi-colour availability depending
on the doping choice. This is of great importance when applying the nannoparticles
as contrast agents for CRS imaging systems where different excitations and, hence,
detected signal are available. This allows one to find applicable nanoparicles with a
contrast that does not overlap with the biological signal generated with the available
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laser system. Thirdly, the power dependence of the emissions is nonlinear [89,95,99–101]
which offers the same advantages for deep tissue image offered by conventional multi-
photon microscopy. Finally, the conversion of infrared excitation into visible emission
further enhances depth penetration in scattering biological tissues.
All reported techniques in the literature have implemented a CW laser with a wave-
length of about 980 nm. This is to take the advantage of the strong absorption cross
section of ytterbium which, consequently, allows for efficient emission. In this section,
for the first time, the upconversion spectroscopy of doped Gd2O3 nanoparticles will be
investigated under an ultrafast pulsed laser combined with a high numerical aperture
lens. Moreover, for this study, it is essential to explore the spectroscopic properties of
the particles before utilising them in imaging in order to specify the approperiate band-
pass filters. Also, the power dependence of the upconversion emission under the pulsed
laser excitation will be investigated. Finally, the upconversion emission dependency on
the excitation wavelength will be explored for the different types of dopants.
The particles were spin coated on a glass coverslip and sealed with another glass
coverslip with parafilm spacer. The sandwiched coverslips were then placed in the mi-
croscope with the coverslip marked ”down”(the coverslip on which the particles have
been coated) facing the objective lens. Then the optical setup described in Section
(3.3.6) was used to collect generated emission in the backward direction under a pi-
cosecond excitation generated by the signal output from the OPO. The filter used to
suppress the excitation beams is either a 900 nm or 750 nm short pass filter depending
on the excitation wavelength. The upconversion emission is collected by the objective
lens and reflected with a dichroic mirror (750nm - long pass) to pass through a 660 nm-
band-pass filter. The filtered light is then focused with a lens onto a photo multiplier
tube. This imaging setup allows for particle localisation whatever the dopant since all
the particles have UCP emissions in this range. After focusing the scan on aggregations
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of the particles, the dichroic mirror was removed from the optical path allowing all the
backward generated UCP emission and reflected portion of the excitation beam to travel
back to the beam splitter polariser then to the spectrometer as explained above. A 150
l/mm gratings was used providing a maximum of 600 nm bandpass range and a spectral
resolution of 0.88 nm.
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Figure 5.13: UCP of different doped/co-doped gadolinium oxide particles. The figure
illustrates the emissions in arbitrary units.
The upconversion photoluminescence spectrum of doped Gd2O3 nanoprticles are
shown in Figure (5.13). Three samples, each doped or co-doped with one or two of the
different doping elements (Yb,Er,Tm), were investigated with different laser excitations
and filters. S3a, S2 and S1 were excited with the 816 nm picosecond pulsed laser and
a 750nm short-wavelength-pass filter was used. It can be seen from the figure that the
three samples exhibit similar red upconversion spectrum. For S3a, which doped with
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5% Er, only pure red emission is detected. The other two convert a portion of the near
infrared photons into green emission. However, the relative red/green intensities are
different.
S24, which is co-doped with 10% Yb and 2% Tm, exhibits efficient upconversion
photoluminescence only when excited at the Yb absorption band at 978 nm (shown in
Figure.5.21). A 900 nm short-wavelength-pass filter was used to suppress the excitation
and a wider range of spectrum was detected. It can be seen that a different spectrum
corresponding to the thulium ions was collected. A similar spectrum was reported in
previous studies with different host crystals [96,102,103]. Only one article reported the
upconversion photoluminescence of thulium in a gadolinium oxide host crystal [104].
However, the detected spectrum range was limited to the blue emission (430 nm -510
nm).
It is interesting to study the upconversion spectrum of the particles under the two
picosecond excitation beams which are used to acquire CRS images of the biological
samples. This is to see how the spectrum would look like in a real imaging experi-
ment where the two excitations are required to obtain CRS images. For this reason
the spectrum of all the types of particles were collected under the standard CRS imag-
ing setup (816nm and 1064nm). It was expected that two types of optical emissions
would be generated in the focal volume: namely, four wave mixing (FWM) and UC
photoluminescence.
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Figure 5.14: The UCP and FWM spectrum of S31. The UCP recorded under 980 nm
excitation whereas the FWM was generated by two collinear excitations (816 nm and
1064 nm).
For Er doped particles, the UC photoluminescence was overwhelming and no FWM
was detectable. However, for Tm doped particles the FWM process was more notice-
able than any upconversion emission (see Figure.5.14). If the 816 nm beam is blocked
and only the 1064 nm is used for excitation, there is no detectable upconversion pho-
toluminescence in the Yb,Tm co-doped gadolinium oxide particles whereas if a longer
acquisition time (60 seconds) is allowed and an average power of 100 mW is used the
red emission can be detected of the Er doped particles(see Figure.5.15). However, this
might not be efficient for imaging purposes where a faster scanning rate is required
(order of microseconds for one point).
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Figure 5.15: UCP of S1 under the 1064 nm excitation at 100 mW. The spectrum was
collected over 60 sec.
Also, the spectra were acquired with single excitation either 816 nm or 976 nm for
those particles doped with erbium which generate upconversion photoluminescence with
the different excitation wavelength. Figure.5.16 shows the spectrum of S30 under the
two excitation wavelengths. It can be seen that a change in the relative intensities of
the red and green photoluminescence is detected.
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Figure 5.16: The effect of changing excitation wavelength on UC photoluminescence.
S30 was illuminated with 816 nm and 976 nm. The relative intensity of the red/green
emission are slightly different.
As mentioned above, the relationship between upconversion photoluminescence and
excitation power is nonlinear [89,95,99–101]. This is a result of the low of conservation
of energy since two or more photons are required to generate a higher energy visible
photons. However, all the reported techniques used a CW laser. It is of great interest
to investigate the power dependency of the UCP in a typical CRS optical system where
picosecond pulsed laser combined with high numerical aperture lenses are used.
In order to achieve this, the optical setup mentioned above to collect the UC spec-
trum was used. However, more considerations were taken into account regarding power.
First, the power of the excitation beam was attenuated using a neutral density filter
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and measured using a power meter. Second, in order to consider the fluctuations of the
power during a scan, the spectral range was extended to cover the excitation peak ( a
portion of the excitation passes through the filter). Then the intensity of the spectrum
was normalised against the intensity of the excitation peak.
Figures.(5.17,5.18,5.19 and 5.22) show the power dependance of the UCP of particles
with different dopant types, concentrations and different excitation wavelengths. In
Figure.5.17 gadolinium oxide particles doped with 1% Yb and 1% Er were illuminated
with a 978 nm picosecond pulse train driven from the signal output of the OPO. The
average power of the laser was attenuated and measured as mentioned above to cover
the range from 20 mW to 200 mW where the power is measured before the microscope.
Although this does not reflect the actual power when the beam is focused by the lens
onto the particles, the relation between the two values(power before the microscope
and in the focal point) is linear. This is theoretically well established because the
percentages of mirror reflectivity and transmission through the lens are independent
of power. The strongest peak of each transition band was chosen to study the power
dependence. Among the red transition peaks the 662 nm peak was investigated and
the 564 nm peak was chosen for the green transitions. It can be seen that for this
range of power the relationship between UCP and excitation power is linear. For the
same particles a different wavelength (816 nm) was used by changing temperature of
the optical parametric crystal of the OPO. Although the 816 nm wavelength is far away
from the absorption band of ytterbium, it produces efficient UCP as mentioned above.
Figure.5.18 illustrates the behaviour of UCP spectra of S1 under 816 nm excitation
of different powers (20 mW to 100 mW). The relation is linear as can be seen in the
power Vs intensities plot of the two strongest peaks (564 nm and 662 nm). The same
experiment was replicated for S2 which was co-doped with 20% Yb and 5% Er revealing
the same linear behaviour (Figure.5.19). Also, particles co-doped with Yb and Tm
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were subjected to the power dependence experiment. However, because these particles
exhibit less efficient visible UCP when compared to Er doped particles, two preliminary
experiments were conducted. The first experiment aimed to find the optimum Tm
doping concentration that provides the most efficient UCP. Figure (5.20) shows the
spectra of four gadolinium oxide particles samples doped with 10% Yb and different Tm
doping concentrations ( 0.5% , 1% , 2% and 4%). The power was tuned to 100 mW and
checked by the power meter before every scan and the spectrum was collected in 1 sec for
each sample. Additionally, the spectra were divided by the excitation peak intensities
recorded by the spectrometer to consider any possible power fluctuations during the
scan. It can be seen that 0.5% Tm is the optimum concentration for the most efficient
UCP emission. The second preliminary experiment was conducted to determine the
most absorbed wavelength which leads to the strongest UCP. This was done by tuning
the excitation wavelength across the range (971 nm - 984 nm) as illustrated in Figure
(5.21). The intensity of the 811 nm peak was plotted as a function of wavelength. It
can be seen that the UCP efficiency is very sensitive to the excitation wavelength with
a maximum emission at 978 nm. According to these two experiments, S24 (10% Yb,
0.5% Tm) was illuminated with 978 nm and the spectrum of the particles was recorded
at different laser powers (see Figure.5.22). The intensities of the strongest peaks (486
nm and 689 nm) from the blue and the red transmissions were plotted as a function of
power. Also, it can be seen that the intensity is linearly proportional to laser power.
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Figure 5.17: UCP power dependence of S1 under the 978 nm excitation of the range of
powers (20 - 200 mW). The plot of power Vs intensities of the two peaks (662 nm and
564 nm) shows linear relation.
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Figure 5.18: UCP power dependence of S1 under the 816 nm excitation of the range of
powers (20 - 100 mW). The plot of power Vs intensities of the two peaks (662 nm and
564 nm) shows linear relation.
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Figure 5.19: UCP power dependence of S2 under the 816 nm excitation of the range of
powers (20 - 100 mW). The plot of power Vs intensities of the two peaks (662 nm and
564 nm) shows linear relation.
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Figure 5.20: UCP of gadolinium oxide particles co-doped with 10% Yb and different
Tm concentrations (0.5%, 1%, 2% and 4%) under a 980 nm picosecond pulsed laser
excitation.
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Figure 5.21: The 811 nm UCP of S24 under constant 100 mW power and range of exci-
tation wavelengths (971 nm - 984 nm). The plot of wavelength vs normalised intensity
shows an optimum excitation wavelength of 978 nm.
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Figure 5.22: UCP power dependence of S24 under the 978 nm excitation of the range
of powers (10 - 130 mW). The plot of power Vs intensities of the two peaks (696 nm
and 486 nm) shows linear relation.
It has been found from the experiments that gadolinium oxide particles doped with
erbium (Er) generate efficient upconversion emission even if the excitation is tuned to
a wavelength far from the absorption band of the ytterbium at 980 nm. This is an
interesting observation for CRS imaging purposes where an 816 nm laser beam is used
as a pump. Also, the upconversion emission for this type of particle is not sensitive
to the excitation wavelength. This is beneficial when using other laser setups or when
conducting CRS spectral experiment where the excitation beam is tuned over a range
of wavelengths, hence particle can be imaged simultaneously.
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5.7 Magnetic relaxivity
As mentioned in Chapter1, well established MRI contrast elements (namely gadolinium
and iron) were used in this study. In fact, Gadolinium is used clinically and administered
to humans in the form of diethylene triamine pentaacetic acid (DTPA) complexes [105].
However, such a solution is not appropriate for optical contrast where more condensed
matter is required for high sensitivity detection. The nanoparticle forms of gadolinium
oxide and iron oxide have been used widely in the literature as MRI contrast agents [80].
In most of these studies, small particle size (not larger than 30 nm) was adopted to
enhance both longitudinal and transverse relaxivities as a result of maximising the
surface to volume ratio. However, the particles used for this study are chosen to be
much larger than this range to be optically detectable. This raises concerns about the
effect of the particle size on its relaxivity. Fortunately, for iron oxide nanoparticles,
Hinds and coworkers proved that micro-sized iron oxide particles are even more efficient
than those of nano-size [106]. This reduces the particle size investigation to gadolinium
oxide nanoparticles because there is no previous study in which longitudinal relaxivity of
these particles of 100 nm size-range was measured. Accordingly, the aim of this section
is to measure the relaxivity of our relatively large gadolinium oxide particles to ensure
that the size is still providing appropriate relaxivity even with their small surface to
volume ratio.
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Magnevist
Vasovist
Figure 5.23: The molecular structures of Magnevist and Vasovist.
In seeking to develop the technique of measuring longitudinal relaxivities for an MRI
contrast agent well known gadolinium based complexes Magnevist and Vasovist were
used as test agents. They are water soluble complexes with the molocular structures
illustrated in Fig.5.23. Magnevist and Vasovist are available with gadolinium concen-
tration of 0.5 mol/L and 1.0 mol/L respectively. The original solutions were diluted
to lower concentrations by adding distilled water. The concentrations used for these
experiments are 0.2, 0.4, 0.6, 0.8, 1.0, 1.2, 1.4, 1.6, 1.8 and 2.0 mM. The different con-
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centrations of the two contrast agent solutions were transferred into glass containers
and placed in the center of the MRI coil. A fast T1 imaging sequence was used to
localised the samples in the scanner. This was followed by applying inversion recovery
sequence with a relatively long repetition time (104 ms) and different inversion times
(50,100,200, 500, 1000, 1500, and 2000 ms). Seven images of the samples were acquired
as shown in Fig.5.24 (b-h) with a sketch illustrating the arrangements of the samples(a).
The images were collected in one stack in the order of the inversion time using ImageJ
software, then, a z-profile was generated for each concentration. The z-profile corre-
sponds to the grey scale value of each concentration in the image at different inversion
time. However, it is important to mention that although the magnetisation is a vector
quantity which might take positive or negative directions, the image grey scale value is
always positive. Accordingly, negative signs were added to some grey scale values so the
curves patterns are matched the theory (see Section (2.2.9)). The signal intensity was
plotted versus inversion time for each concentration and curve fitted to Equation2.20
as shown in Figure5.25. The constants in the equation (M0 and T1 were retrieved from
the curve fitting calculations. Plotting concentrations vs 1/T1, the longitudinal relax-
ivity can be obtained by curve fitting the data to Equation2.22 where the slope is the
relaxivity. The relaxivities of Magnevist and Vasovist were found to be 4.56 s−1mM−1
and 6.80 s−1mM−1 respectively. For the same conditions, the relaxivity values match
those reported in the literature for both Magnevist [81] and Vasovist [105].
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Figure 5.24: The samples arrangements (a) and inversion recovery images (b-h) of
different concentrations of the clinically used contrast agents Magnevist and Vasovist
at different inversion times as illustrated on the images.
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Figure 5.25: The longitudinal relaxivity measurements of Magnevist (a and b) and
Vasovist (c and d). The plots of signal intensity versus inversion recovery time are
shown in figures (a and c), where the symbols represent the data points and the solid
lines are the curve fits of the different concentrations as illustrated in the legends. The
plots of 1/T1 as a function of gadolinium ions concentrations are shown in figures (b
and d).
The above measurements were carried out using water as a solvent for the water
soluble Gd-based contrast agents. However, the large nanoparticles used for this study
do not suspend in water. It was noticed that they gradually settle at the bottom of the
container which makes the concentration change with time. The proposed alternative
was to use agarose gel to maintain constant concentration of the particles during the
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MRI experiment. However, it was necessary to insure that replacing water with gel
did not significantly affect the T1. Accordingly, Magnevist samples were prepared with
different concentrations (0, 0.2, 0.4, 0.6, 0.8, 1.0, and 1.2 mM) in water and 0.5 w/w
agarose gel. The samples were placed in the MRI scanner and a T1-weighted imaging
sequence with TR/TE = 20/16 ms was applied. The head coil was used to achieve
better signal to noise ratio. The resultant image was then opened in ImageJ software
where the signal intensity and standard deviation of each sample were obtained.
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Figure 5.26: The signal intensity of a T1-weighted image of different concentrations of
gadolinium ions (Magnevist) in water and gel.
Figure5.26 shows the plot of gadolinium ions concentrations vs signal intensity of
water and gel samples. The error bars are the standard deviation values and they are
greater in gel samples than those of water because of the inhomogeneity of the gel. It can
be seen that the two sets of data have no remarkable difference and with overlapping
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error bars. This suggest that it is possible to compare relaxivity measurements of
particles in gel with the reported relaxivity of other contrast material in water.
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Figure 5.27: Relaxivity measurements of 100 nm gadolinium oxide particles in gel. a)
is the inversion recovery curves and (b) is the longitudinal relaxivity of the particles.
Figure (c) is the decay curves at different TE and (d) is the transverse rlaxivity.
The gadolinium oxide nanoparticles (100 nm) were purchased from Sigma Aldrich,UK.
In order to prepare different concentrations of the particles, 29 mg of powder was added
to 20 mL of distilled water which results in 4 mM of the gadolinium ions. The mixture
was then sonicated for 30 min and diluted into smaller concentrations by adding (1 mL,
900 µL, 800 µL, 700 µL, 600 µL, ......,100 µL) of the original mixture to (0 mL, 100
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µL, 200 µL, 300 µL, 400 µL, ......,900 µL) respectively. The resultant mixtures are 1
mL each with gadolinium concentrations of (4 mM, 3.6 mM, 3.2 mM, 2.8 mM, 2.4 mM,
......, 0.4 mM). Then, 1 mL of 1 % gel was added to each container and mixed until
white foggy colour is achieved, then the containers are cooled down in an ice bath to
conserve the uniform particle distribution. The longitudinal relaxivity measurements
were acquired using the same inversion recovery sequence and ImageJ software proce-
dures described above. The results are showed in Figure(5.27,a and b). It can be seen
that the data points are widely scattered around the fitting straight line and a very low
longitudinal relaxivity was obtained. To understand the possible reason the transverse
measurements were also acquired for the same samples. A set of T2-weighted spin echo
images were acquired with a TR= 3000 ms and different echoes at (20, 40, 60, .....,
140, and 160 ms). The eight images were collected in a stack and z-profile of the signal
intensity for each concentration. The z-profile data represent the signal intensities at
the different echoes. In Figure(5.27,c) the data points are the experimental data of the
signal intensity as a function of echo time whereas the solid lines are the curve fits of
the data to Equation2.18. From the curve fit, the T2 of each concentration is obtained
as marked in the legends. Figure(5.27,d) shows the plot of 1/T2 as a function of concen-
tration from which the transverse relaxivity was calculated by curve fitting the data to
Equation2.20. It can be noticed that the data points of the transverse relaxivity in Fig-
ure(5.27,d) seem to obey the straight line better that those in the longitudinal relaxivity
data points in Figure(5.27,b). Also, the transverse relaxivity is more significant than the
longitudinal one. This might be a result of particle aggregation. The aggregation seems
to affect r1 (longitudinal relaxivity) more than r2 (transverse rlaxivity) because T2 can
be altered by the magnetic contrast agents in a long range manner [10] whereas direct
contact between the protons and the paramagnetic material is required if T1 contrast is
desired [21] . That explains also why in shell-core particles T2 based contrast material
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is placed inside the core and for the shell a T1 based contrast material is chosen [107].
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Figure 5.28: A replication of the data in Figure.5.27 with a better particle distribution
and less aggregations.
In order to overcome the aggregation problem, a commercially available dispersing
agent (DISPERBYK-190) was used in 1 % w/w concentration as described in reference
[108]. The samples were prepared again in a similar way to the method mentioned
above except that the dispersing agent was added to the Gd2O3-water mixture before
sonication. Also, only five concentrations of gadolinium ions were prepared this time (2,
1, 0.5, 0.25, 0.125 mM). The same MRI sequences and ImageJ analysis were applied to
obtain the relaxivity measurements of the laterally prepared samples ( See Figure5.28).
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It can be seen that the exponential recovery and decay curves of different concen-
trations in the inversion recovery (Fig.5.28,a) and spin echo (Fig.5.28,c) have different
gradient which are the theoretically expected behaviour (as in Eq.2.20 and Eq.2.18).
Consequently, better straight line fit was achieve for both longitudinal(Fig.5.28,b) and
transverse (Fig.5.28,d) relaxivities. Moreover, and most importantly, the longitudinal
relaxivity of the relatively large gadolinium oxide nanoparticles (100 nm) is found to
be similar to those calculated for clinically used complexes. This result allow us to
confidently propose these particles for the multi-modal imaging approach suggested in
this study. Also, for the scientific community, it might be interesting to know for the
first time that this size of gadolinium oxide nanoparticles work efficiently as T1 contrast
agents in the widely available 1.5 T clinical scanner.
5.8 Summary
In this chapter the structural, morphological, optical, and magnetic properties of the
nanoparticles were characterised. The composition materials and doping of gadolinium
oxide nanoparticles were confirmed by X-ray energy dispersive spectroscopy. Also, XRD
spectrum confirmed the crystalline structure which is vital for the particles to expose
photoluminescence properties and provided another evidence confirming the compo-
sition of the materials. The morphology of the particles were inspected using SEM
and TEM. It was found that Gd2O3 nanoparticles form in a spherical shape whereas
a cubic shape is obtained when synthesising iron oxide nanoparticles with a tuneable
particle-size for both types. Both synthesising methods, homogenous precipitation and
hydrothermal, provided acceptable level of size monodispersity which cloud potentially
improved if surfactants are used. The photoluminescence properties of the particles
were studied using a compact Raman micro-spectrometer equipped with two excitation
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CW lasers (532 nm and 785 nm). An extended range of PL spectrum was recorded for
particles doped or co-doped with different rare earth ions (Yb, Er, Tm). It was found
that efficient photoluminescence is detected even when using low power, minute parti-
cle concentration and less magnification lens. The efficient photoluminescence emission
also confirms the successful doping and the crystalline structure. The UC photolumi-
nescence spectrum of doped gadolinium oxide nanoparticles were investigated for the
first time under a pulsed laser excitation and high numerical aperture lenses, a typical
optical setup of acquiring CRS images of biological structures. The UCP dependence
upon laser power, excitation wavelength, and doping concentration was investigated.
The most interesting observation is that gadolinium oxide nanoparticles doped with Er
provide a strong UCP in the whole available range of excitation wavelength. Although
UCP is recognised as a nonlinear process the relationship between the laser power and
signal intensity was found to be linear due to a saturation effect. To ensure that gadolin-
ium oxide particles exhibit acceptable longitudinal relaxivity with their relatively large
size (100 nm), they were subjected to MRI relaxivity measurements in a 1.5 T scanner.
It was found that the relaxivity of the particles is comparable to clinically used contrast
agents.
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Chapter 6
Nanoparticle optical imaging
6.1 Introduction
Multi-functional nanoparticles have been used widely in recent years for multi-modal
imaging, targeted drug delivery, gene therapy and photodynamic therapy (the reader
is referred to articles [109–112]). Multi-modal imaging is desirable for its capability in
assisting the efficiency and credibility of the under-investigation therapeutic methods
in different imaging scales and contrasts. The multi-modal nanoparticles investigated
in this study are required to possess optical and magnetic properties that allow the
combination of the advantages of large scale 3D MR imaging and the high resolution
CARS microscopy to image particles in biological tissue at the cellular scale. In MRI
there are two main types of contrast particles, longitudinal (T1 based contrast agents)
and transverse (T2 based contrast agent). Each type has its own advantages and ap-
plications to target specific kinds of organs and tissue. For this reason two types of
particles with T1 and T2 contrast are investigated.
Among the multi-modal imaging nanostructures, fluorescent dye-coated iron oxide
nanoparticles and lanthanide doped gadolinium oxide particles have been imaged with
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MRI and optical imaging techniques for their magnetic and optical properties [113] [114].
Both types of particles have unpaired electrons in their outer shell of iron and gadolinium
providing them with the paramagnetic properties that alter both T1 and T2 of the
biological tissue. However, iron oxide nanoparticles and gadolinium oxide nanoparticles
are considered as T2 and T1 based contrast agents respectively for the ratios of their
longitudinal and transverse relaxivities.
The optical contrast of iron oxide nanoparticles is gained by a dye coating ma-
terial which allows fluorescent imaging with conventional laser scanning confocal mi-
croscopy [113] [114] [20] [15]. In these studies the contrast of the living cells was achieved
with different fluorescent dye staining, transmitted light or labeled with the particles
themselves.
The doped gadolinium oxides nano-structures pose optical properties for the 4f tran-
sitions that occur in doping lanthanide ions either with normal photoluminescence or
up-conversion photoluminescence. A number of previous studies utilised the photolu-
minescence properties of doped gadolinium oxide nanoparticles for confocal microscopy
imaging. This was demonstrated using blue or ultra violet excitation and detecting
longer wavelength light emitted by the nano-structures [19] [115]. The upconversion
process was adopted in imaging in two different methods, whole animal infrared imag-
ing and confocal microscopy. The whole animal infrared imaging was carried out using
980 nm excitation laser and a filter fitted to a CCD camera to detect the shorter wave
length emitted by the nanoparticles in a dark room. The image is merged with another
white light image of the animal taken with the same camera from the same position
to assign the particle location to the animal body [116] [8]. The upconversion photolu-
minescence (UCL) confocal microscopy was developed by utilising the same excitation
laser in a confocal microscopy setup to image the particles in a high resolution 3D
manner in the biological context [110,112].
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As mentioned before, CARS microscopy has several key advantages when compared
to the conventional confocal microscopy. For this reason there is interest to develop a
technique that images these magnetic particles with CARS microscopy systems. This
imaging technique should provide different contrast of the particles so they can be im-
aged and localised in 3D within the biological contents of the tissue at cellular resolution.
There is only one previous study that payed attention to this demand. This was carried
by Rago and coworkers in 2011 who studied the possibility of visualising micrometer-
sized iron oxide particles with FWM [30], however, such particle size is not suitable for
drug delivery applications.
In this Chapter, armed with the spectroscopic data from the previous chapter, the
possible imaging techniques that can be used to image iron oxide and lanthanide doped
gadolinium oxide nanoparticles in CRS microscopy systems are explored. Moreover,
the particles will be imaged within a stable biological model sample (starch) to show
the possibility of obtaining distinguishable contrast. Starch is an appropriate biological
model sample for its strong CH2 Raman signal which is similar to lipids in living cells.
6.2 Confocal imaging
The novel optical properties of doped gadolinium oxide nanoparticles allow imaging
them with a conventional confocal microscope. Several groups have already investigated
this. The imaging is carried out in two different methods either using photouminescenc
or upconversion photoluminescence. The former is achieved by detecting the visible
emissions after exciting the particles with a shorter wavelength laser, whereas, an in-
frared excitation is used in the latter. However, there was no evidence in these studies
that single particles can be detected. When particles suspended in solution they usually
aggregate and form larger structures. The aim of this section is to explore the applicabil-
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ity of the particles when imaged with confocal microscope via their photoluminescence
properties.
As mentioned earlier, a uniform 2D distribution of the nanoparticles was achieved
by spin coating them on glass coverslips. This was confirmed with scanning electron
microscope(SEM) and example images are given in Figure (6.1). Four images of different
magnifications of S3a are presented (scale bars provided). It can be seen from the images
that, although there are aggregations of the particles, the overwhelming number of the
particles are found singles and separated by more than 300 nm in 2D distribution. Also,
similar 2D distributions were achieved repeatedly with different types of particles with
high reproducibility.
a)
c)
b)
d)
Figure 6.1: SEM of sample 3a.
In the confocal microscope, an excitation of blue argon CW laser was used. The
objective was a 63X oil immersion lens and two magnifications of the images were
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used. Three channels recorded the images with different contrasts, two for detecting
the photoluminescence spectrum in which tuneable filters was set up to cover specific
ranges and the third channel used to acquire the transmission light. Figure(6.2) shows
six images of the nanoparticles(S2). The images on the right hand side are of 10x
magnification whereas the images on the left correspond to 2x magnification. Images (a
and b) are acquired with the first channel covering a spectral range of 500-600 nm. The
spectral range 600-700 nm, was acquired and presented with images (c and d). Finally,
images (e and f ) recorded the transmitted light.
These images of the doped gadolinium oxide particles were acquired by detecting
the photoluminescence emissions as illustrated in Figure(6.3). The emissions detected
by CH1 are due to the transitions from 4S3/2 and
2H11/2 to
4I15/2 whereas CH2 recorded
the red emissions between 4F9/2 and
4I15/2 [95]. It is clear that the intensity of the
particles in Figure(6.2 a and b) are brighter than those of Figure(6.2 c and d). This is
a result of the relative difference of the intensities of the two spectra (see Figure(6.3))
as well as the wavelength detection dependence of the PMTs.
In Figure(6.4) three images of S22b are presented. The first image was acquired
by detecting the green emission (500-600nm) and the second image is the transmitted
light. The third image is an image of merging the two channels. It is clear that the
signal of the particles located in the centres of the circular patterns observed from
the transmission channel. Combining this with our previous knowledge about particles
distribution formed by spin coating and confirmed by SEM, it can be concluded that
imaging single particle was achieved.
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Figure 6.2: Confocal microscopy images of S2 particles at different zoom and detection
spectra as labeled on the images.
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Figure 6.3: The spectral ranges covered by the red and green channels of the Confocal
microscope.
a) b) c)
Figure 6.4: Confocal imaging of sample 22b: a) recording the transmission light b)
detecting the green spectrum, and c) merging a and b images.
In this section the photoluminescent properties of our particles are proved to be
efficient for confocal imaging which bring them to the standard of those reported in
the literature. Moreover, unlike particles reported before, conclusive result show single
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particle detection. However, although confocal microscopy is widely used in biology, it
has several weaknesses that make it not appropriate for the purpose of this study. First,
biological tissue should be stained with specific dyes to gain cellular contrast under
the microscope, which complicates the biological system in which the nanoparticles
distribution is investigated. The second drawback is the fact that confocal microscopy
relies on a pinhole to achieve the imaging plane confinement, which significantly limits
optical penetration depth in scattering tissue such as brain.
6.3 FWM imaging
Four wave mixing (FWM) has proved to be a powerful technique to image inorganic
nanoparticles in a biological context [46, 117]. However, as mentioned in section 2.3.6
there was only one study where this process was utilised to image magnetic particles [30].
The particles investigated in that study were in the micro-size range. In this section,
four wave mixing process will be applied to image magnetic nanoparticles (iron oxide
and gadolinium oxide) dried on microscope glass coverslips, embedded in agarose gel,
and mixed with starch as a model CH content.
The optical setup used here for FWM imaging was described in Section(3.3.3). Two
co-aligned pulsed laser beams (816 nm and 1064 nm) were used to produce the FWM in
the magnetic particles in the focal point. The wavelengths of the two beams were chosen
to be a set of the typical combinations used to achieve C-H vibrational contrast of the
biological structures. Moreover, this combination of wavelengths is more desirable for
imaging scattering tissue such as brain as explained before in Section(4.3.2). Therefore,
it is appropriate to apply the same excitation beams to image the magnetic particles.
In order to investigate the possibility of imaging gadolinium oxide nanoparticles
(bought from Sigma Aldrich) with FWM, a droplet of the particle-water mixture was
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dried on a microscope glass coverslip by placing the coverslip on a hot plate at 50◦ c.
The coverslip was then sealed and placed in the microscope and imaged with the CARS
setup and wavelengths mentioned above. Figure(6.5, a) shows a 512 × 512 image of
aggregations of the Gd2O3 nanoparticles. In Figure(6.5, b) same setup was applied to
image the particle aggregation. However, the 816 nm and the 1064 nm beams were
blocked while scanning the particle as illustrated in the image. The red horizontal lines
represent closing and opening shutters. It can be seen that the signal comes from the
particles only if the two beams are applied. This confirms that this signal results from
four wave mixing, since, according to our previous knowledge of the FWM spectrum
generated by gadolinium oxide nanoparticles(see Section(5.6)), the signal fits within the
spectrum band detected by the filter 660/40 nm; the particles are not doped which
indicates that they do not generate an UCP signal; even if the UCP signal is generated
it could be generated by the 816 nm only which did not occur as when the 1064 nm was
blocked no signal was detected.
845.4nm'is'oﬀ'
1064nm'is'oﬀ'
a) b)
1064 nm  
is blocked 
816 nm is 
blocked 
5 µm
5 µ
5 µm
Figure 6.5: A FWM image of aggregation of gadolinium oxide nanoparticles, a) with
continuous scanning with both beams (816 nm and 1064 nm) whereas in b) one of beams
was blocked as labeled and determined with the red dashed lines.
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In order to investigate the FWM of iron oxide particles, commercially available 200
nm particles were purchased from microParticles GmbH. The particles were suspended
in 0.03 % of the original concentration in 1% w/w agarose gel. A droplet of the resultant
particle-gel suspension was dropped on a microscope glass coverslip and sandwiched with
another glass coverslip and sealed with parafilm spacer as described before. A z-stack
of 40 images were taken of field of view of (157 × 157 µm2 ) and with a 0.5 µm step in
the z-direction which covers a volume of 157 × 157 × 20 µm3.
Z-stacks were opened in ImageJ software and a z-projection was taken Figure(6.6,
a). Also, to see the confinement of the particle in the z-axes, the stack was resliced
using the same software in the xz-direction and y-projection was taken and shown in
Figure(6.6, b). The bright dots in the images show the locations of the particles, however
there is no conclusive evidence that single particle imaging was achieved. Nevertheless,
qualitatively, a relatively stronger signal was achieved. Moreover, from Figure(6.6, b)
it can be seen that small dots which are not spreading in the z-direction confirm that
sharp z-confinement was achieved as a result of the nonlinear FWM process. If the
relationship between the laser power and emission was linear the particles would appear
unconfined in the z-axes similar to those in Figure (6.8, b).
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Figure 6.6: A FWM image of iron oxide particles suspended in agarose gel, a) a z-
projection with FOV in xy-plane of (157 × 157 µm2 ) and b) a y-projection with FOV
in the xz-plane of (157 × 20 µm2). The bright spots indicate the particles.
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In the previous paragraph an efficient nonlinear FWM signal was achieved using com-
mercially available iron oxide microparticles. Here, the iron oxide nanoparticles(S21)
were spin-coated on a glass coverslip as described before. The particles were imaged
using the CARS setup (λpump =816 nm ,λstokes = 1064 nm). The image is shown in
Figure (6.7) with Field of view of (157 × 157 µm2). This experiment was conducted
to confirm that same efficient signal can be generated from the fabricated nanoparticles
(S21, 70 nm).
15 µm
Figure 6.7: A FWM image of iron oxide nanoparticles (S21) spin coated on a glass
coverslip. The image size is (512 × 512 pixels) with field of view of (157 × 157 µm2).
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6.4 Upconversion imaging
Despite the large number of works in the literature to applying gadolinium doped par-
ticles in biomedical imaging, there has been no work toward utilising them in a pulsed
laser system combined with high numerical aperture lenses. Such systems are required
to acquire CARS images of biological tissue in a label free manner which is suggested
by this study as a powerful modality for monitoring targeted drug delivery and contrast
agents. In this section doped gadolinium oxide nanoparticles will be investigated under
typical laser excitations. The investigations will deal with signal strength, optimum
scan time, and nonlinearity of the signal.
Doped gadolinium oxide particles (S1) were spin coated on a glass coverslip and
prepared for imaging as detailed earlier. The CARS setup used to image the particle
utilised the excitation wavelengths 816 nm and 1064 nm. The filter used for detection
scheme is also the filter used for CARS for this excitations combination (660 nm band-
pass filter). Sample (S1) was chosen for this experiment as it is one of the samples
with erbium dopant which is vital for the particles to exhibit efficient upconversion
photoluminescence under the 816 nm excitation as concluded in Section(5.6).
Figure(6.8, a) shows an UCP image of the particles which was acquired using CARS
setup and excitation power with typical PMT voltage used to image CARS and a reason-
able scan time 10 sec/frame. The detected signal is efficient to the standard of sensitivity
of the detection scheme. In Figure(6.8, b) a line scan was acquired with the microscope
to investigate the ability of z-confinement of the particle signal. As mentioned in sec-
tion(6.2) the spin coated particles form a uniform 2D distribution as confirmed by SEM
images. On one hand, this 2D layer is of particle diameter thickens (in this case with
sample particles it is 280 nm). On the other hand, the microscope is capable of ac-
quiring z-step of 0.5µm. It is an effective method to examine the z-confinment of the
160
Chapter 6. Nanoparticle optical imaging
microscope using UCP of the particles. If the UCP signal is generated in a nonlinear
manner, the signal will be orders of magnitude higher when the focal point scans on the
particles layer. When the focal point scans above or beneath the particles layer the pro-
duced signal should be much lower and undetectable with that same PMT voltage used
to detect the in-focus signal. This is the main concept of nonlinear (or multi-photon)
microscopy which is explained in Section(2.3.3). However, it can be seen in Figure(6.8,
b) that UCP signal is generated efficiently even if the particle layer is out of focus. This
is a result of the linear behaviour of the UCP discussed in section(5.6). Although UCP
is a nonlinear process, it suffers from saturation which drives the relationship with laser
power to a linear manner at relatively high power. It seems that the saturation limit
is far below the sensitivity of the CARS detection setup. Also, the pico second pulsed
laser is not the correct choice for producing efficient nonlinear UCP signal at low powers.
The pulse peak intensity is above the saturation limit even if the average power is lower
than the saturation limit. If the average power is attenuated so that the peak power is
below the saturation limit, the generated signal is not efficient for imaging.
Although the loss of z-confinement of the particles is considered as a disadvantage,
it might be a novel advantage for the purpose of multi-modal drug tracking in brain
tumours with MRI and CARS. As mentioned in Section(4.3.2), one of the main obsta-
cles of comparing MRI and CARS images is the different scale image dimensions and
resolution. A CARS mosaic image is just 0.5 µm thick, whereas, a high resolution MRI
image can be 100 µm. The unconfined signal of the particles will be detected from a
slice with a thickness of about 20µm above and underneath the CARS image. This
will help to locate particles in the thick brain slice as a first step, and a z-stack can be
applied to any region of interest accordingly.
161
Chapter 6. Nanoparticle optical imaging
Δx = 157 µm
Δz
 =
 2
0 
µm
a)
b)
15 µm
Figure 6.8: a) In focus UCP 512 × 512 image with 157 × 157 µm2 FOV of Gd2O3:1 %
Yb, 1% Er particles taken with 816 nm excitation and 660/40 nm detection filter and
typical CARS PMT voltage. b) A line scan generated with the microscope software
allowing xz-plane imaging with FOV illustrated in the figure.
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Another important characteristic of UCP is the relatively long lifetime of the emis-
sion. In order to address this, Figure(6.9, a) is a 250 × 250 image of doped gadolinium
oxide nanoparticles (S2) acquired under 816 nm excitation with scan speed of 2010
ms/frame (or 32 µs/pixel). Because the UCP lifetime is longer than the pixel dwell
time, a decaying blurry edge is produced in the image towards the scan direction. An
estimation of the decay time was undertaken to consider its effect in any further UCP
imaging. In Figure(6.9, a) a yellow line and its grey scale value profile in terms of pixel
distance was produced with ImageJ software. The line profile (Figure(6.9, b)) corre-
sponds to signal decay as a function of time after replacing distance in pixels with the
corresponding scan time. The data points were then fitted to the equation I(t) = I0e
(−t/τ)
revealing the value of τ to be 200 µs.
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Figure 6.9: This is an illustration of the decay time effect on the image. On the left (a)
is a (250 × 250) image of aggregations of doped particles(Sample 2) excited at 816 nm
at scan speed of 2010 ms/frame. The plot in (b) is the intensity profile of the yellow
line drawn in image (a).
Although the decay lifetime is close to that previously reported [88], it is important
to mention that the aim of this experiment was not to accurately measure decay lifetime,
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but to estimate the decay lifetime and consider its effect on the imaging process.
Figure(6.10) shows three 512 × 512 UCP images (a, b, and c) of doped gadolinium
oxide particles acquired at different imaging speed (3.8 µs/pixel or 1 s/frame, 42 µs/pixel
or 11 s/frame, and 191µs/pixel or 50 s/frame, respectively). To understand the effect of
the scan time on the image the line profile of the grey scale value of the white lines drawn
on the images were generated using ImageJ software and plotted in Figure(6.10, d). The
intensity profiles are shown in different colours and labeled in the legends. It can be
seen that that the red profile is shifted with a large number of pixels with disappearing
of some small peaks under the decay of more intense peaks. However, the other two
intensity profiles corresponding to images (b) and (c) are showing similar behaviour
with excising of all the peaks and an ignorable minor shift. It can be concluded that
UCP particles can be imaged with reasonable scan time of 42 µs/pixel. This time is
required anyway when imaging highly scattering tissue such as brain.
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Figure 6.10: The effect of imaging speed on the upconverting nanoparticles image.
Three images of the same sample (a,b and c) were acquired with the same laser power
(100 mW) and different scanning time where a 660/40 nm wavelength-bandpass filter
was used. The scanning time is shown on each image in microsecond/pixel and sec-
onds/frame. The profiles of the three white lines drawn on the images are plotted in
(c).
As mentioned in the introduction starch was used as a model to investigate the
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possibility of imaging doped gadolinium oxide nanoparticles in biological structures.
Nanoparticles from sample (S3a) were mixed with starch and two images were acquired
with different excitations and same typical CARS detection bandpass filter 660/40 nm
(see Figure. 6.11, a and b). Image (a) was taken with single beam excitation (816 nm)
and the detected signal is the UCP of (S3a) at this range of the spectrum as illustrated
in Figure(6.12). In Figure(6.11, b) two synchronised pulse excitations (816 nm and 1064
nm) were applied resulting in generating both CARS from starch, FWM and UCP from
the particles. However, in particles, UCP is the overwhelming as illustrated previously
in section(5.6). Using ImageJ the two images were composed in one image using the
merge colour function. The resultant composite image shows the structure of starch
and the distribution of the particles in a distinguishable contrast. These two images
were acquired in two different scans to enable the researcher to change excitation setups
which might be considered as a drawback. However, simultaneous imaging of the two
types of signal (UCP and CARS) can be achieved by using different emission filters.
As illustrated in Figure(6.12), the UCP signal of the particles covers a wider range of
spectrum (650 nm - 685 nm) whereas FWM is a narrow peak located at 660 nm. If, for
instance, two wavelength-bandpass filters (660/20 nm and 680/20 nm) with two PMT
detectors are used, simultaneous imaging is possible. Also, different doping can be used
to detect different colour of UCP emission, however, due to cost implications, the work
in this thesis is limited to the available CARS setup.
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Figure 6.11: Imaging the upconversion nanoparticles in a biological context
model(starch). In image (a) the upconversion photoluminescence was detected after
a single beam excitation (816 nm) whereas two beams were used to generate the epi-
CARS of starch (b). The composite of the two images (a and b) is presented in image
(c) showing the localisation of the doped gadolinium oxide particles within the biological
context model.
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Figure 6.12: The spectra range covered by the 660/40 nm band pass filter of the UCP
and FWM.
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6.5 Two photon photothermal lensing (TPPL) imag-
ing
As mentioned in Section(2.3.8), two photon photo-thermal lensing is an imaging pro-
cess that relies on detecting the modulated defocusing of a laser beam as a result of
local thermal gradient in the focal volume caused by another. This process was used
to image heme proteins with a conventional SRS setup [49]. As an emerging applica-
tion in biological tissue imaging TPPL process was used to gain contrast of red blood
cells and, hence, measure the blood vessels density in 3D [118]. However, in terms of
nanostructure spectroscopy, Gold nanoparticles were detected via their surface plas-
monic resonance absorbing properties [119]. Moreover, single nanoparticle was detected
using same thermal properties of metallic nanoparticles in another previous study [120].
In this section, we show for the first time that iron oxide nanoparticles can be imaged
using TPPL with the picosecond-laser SRS setup. Also, a possible physical explanation
of how this process occurs in such semi-conducting material will be discussed.
The SRS setup used in this section was presented in Section(3.3.4). Briefly, two
collinearly alined picosecond pulsed laser beams (1064 nm and 816 nm) were temporally
overlapped and directed to pass through the objective lens of the microscope. The
1064 nm pulse train was modulated at 1.7 MHz and a lock-in amplifier was set to
detect variations in signal at the same reference frequency. Two different sized iron
oxide nanoparticles (S20, S21) were synthesised using hydrothermal method described in
Section(3.4.1). Samples were prepared by distributing the particles on a glass coverslip
(single layer) as illustrated before then placed in the microscope for imaging. From the
first trial and without changing any of the typical setup used for lipids SRS imaging a
strong signal was detected in the lock-in amplifier resulting in a relatively high intensity
signal in the grey scale image. FWM was recorded simultaneously in the backward
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direction as illustrated in Section(6.3) to confirm the detection of iron oxide particles.
(a) (b)
FWM TPPL
S21
S20
(c) (d)
15 µm 15 µm
15 µm 15 µm
Figure 6.13: FWM and TPPL of iron oxide nanoparticles (S20 and S21).
Figure(6.13) shows both FWM (a,c) and TPPL (b,d) images of S20 and S21. The
overwhelming observation is the relatively stronger signal recorded in the TPPL channel
compared to CRS suggesting enhanced sensitivity of the thermal lens process. Moreover,
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particles can be seen at full image FOV edges without loss of signal which confirms that
the process does not require phase matching as in FWM and CRS.
Another experiment was conducted to investigate the z-confinement of the particles
in a TPPL image and hence the nonlinearity of the power-signal dependency. A z-stack
of 40 images of (157 × 157 µm2) with a z-step of 0.5 µm was acquired using the 60x
lens. The resultant z-stack image was opened with ImageJ and was re-sliced in the x-z
plane direction (x is one arbitrary axes of the two in-plane axes of the original image).
Then, a projection of the x-z images was produced (see 6.14). The resultant image
dimensions are labeled on the image( 20µm × 157µm). A series of bright dots that lay
on approximately a straight and horizontal line can be seen in the middle of the image.
These bright spots indicate a projection of the particles on the glass coverslip. The
z-confinement of the particles proves that nonlinear dependency between laser power
and generated TPPL signal is achieved.
Δx = 157 µm
Δz
 =
 2
0 
µm
Figure 6.14: The z-confinement of the TPPL signal detected from iron oxide nanopar-
ticles (S21).
After having achieve a clear z-confinement of the particles with TPPL, it is interest-
ing to see how these particles would appear in a biological context and if the contrast will
be distinguishable. For this purpose a mixture of the particles and starch was prepared
as described earlier. Figure(6.14) shows images of the mixture with recorded in the
forward (SRS and TPPL) and in the backward (CARS andFWM) directions using the
170
Chapter 6. Nanoparticle optical imaging
same Stoke beam and different pump beam wavelength. When using C-H vibrational
resonance set of beams (816 nm and 1064 nm), starch appear bright for the anti-Stokes
CARS signal detected in the epi-direction (Figure6.15,a). Also, particles in specific size
and locations can be seen in (Figure6.15,a) for the FWM process which was explained
before in section(6.3). A simultaneous image was acquired in the forward direction and
presented in (Figure6.15,b) showing SRS of the starch and TPPL of the particles. The
particles show relatively stronger TPPL signal and larger spots than those detected
of them with FWM. This might be a result of the nature of epi-detected signal, since
only small aggregations of the particles (smaller than 1/3 of the wave length), or, those
located in an interface allowing them to reflected signal generated by starch or glass
coverslip, will show up in the image [28]. It is interesting to investigate the effect of
changing the wavelength of the pump beam driven from the OPO to a value close to
the off resonance frequency. This will exclude any doubts that the signal might be orig-
inating from starch since CH bonds would appear dark in the image. Hence providing
additional evidence since we already imaged the particles without mixing them with a
biological material before, see Figures(6.13 and 6.14 ). As expected, when tuning the
wavelength of the OPO beam to 810 nm, signals from starch in both e-CARS and SRS
is reduced (Figure6.15, c and d). Also, the pump wave length was tuned to 807 nm
(Figure6.15, e and f ) where in image(e) no CH signal is detected of starch, and only
non-resonant signal of the glass is recorded. In image (f) only TPPL signal of the par-
ticles is detected which is considered as a distinguishable contrast from the biological
model context.
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Figure 6.15: The figure shows 6 images, (a,c and e) acquired at different pump wave
lengths of Epi-CARS of starch and FWM of iron oxide particles detected in the backward
direction, and (b, d and f) recorded SRS of starch and TPPL of the particles.
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Another technique that can be used to provide contrast between particles and biolog-
ical structure is desynchronising the two excitation pulse trains. Unlike CRS processes,
TPPL does not require temporal overlap of the pulse trains. Figure (6.16) shows images
where the two excitation pulse trains were synchronised (a,b) and where pulse trains
were desynchronised until no epi CARS signal was detected (c,d). It can be seen that
TPPL signal of the particles is detected in image (d).
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Figure 6.16: The figure shows 4 images, (a and c) acquired of Epi-CARS of starch and
FWM of iron oxide particles detected in the backward direction, and (b and d) recorded
SRS of starch and TPPL of the particles, with the pump and Stokes pulse train either
synchronised (a and b) or desynchronised (c and d).
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Changing the wavelength of the pump excitation and desynchronising the two pulse
trains are available techniques to differentiate between particles and biological context
as mentioned above. However, this requires the investigator to acquire images in two
separate sessions which is considered as a limitation. Fortunately, as reported in previous
studies TPPL signal does not arrive at the detector simultaneously with the SRS of an
active vibrational bond. It has previously been shown [118] that the difference in phase
(with respect to pump modulation) of SRS and TPPL processes can be exploited to
separate the two processes using phase-sensitive lock-in detection. Similar technique
can be used to differentiate between particles and biological structures. This, however,
should be proceeded by inspecting the phase difference between TPPL of particles and
SRS of CH bonds in starch. For this reason, ten images of the starch particles mixture
were acquired for different phases (0◦,20◦,40◦,60◦,...,160◦,180◦) with respect to pump
modulation. The images were normalised against laser fluctuation and the variation in
signal intensity of two spots in the image that represent particle aggregation and starch
were measured in arbitrary units using ImageJ. The particles and starch spots were
confirmed by FWM detected in the backward direction at a nonresonace wavelength.
Figure (6.17) shows the variation in signal intensities of SRS of starch and TPPL of the
particles as a function of detected phase.
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Figure 6.17: The signal intensities of SRS of starch and TPPL of iron oxide particles as
functions in phase.
In Figure(6.17) it can be seen that the signal of the particles can be isolated by
choosing the 160◦ phase image. Baring that an available epi-CARS image showing
starch was acquired simultaneously with this image, the two images were merged in
two different colours to display the distribution of the particles within the biological
model(see Figure(6.18)). In the figure TPPL signal of particles is shown in green and
the epi-CARS of the starch appears in red.
In this experiment the backward direction was available to detect a simultaneous
epi-CARS image of starch, however, in other experiments another imaging technique is
used to image different biological structure for a specific purpose (for instance Second
Harmonic Generation to image collagens). In such experiments the forward direction
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is enough to detect both SRS of starch and TPPL of iron oxide particles. This can be
achieved by detecting amplitude and phase of the signal and post image processing can
be carried out to produce distinguishable contrast of particles and starch.
15 µm
Figure 6.18: A composite of two images epi-CARS of starch (red) and TPPL of iron
oxide nanoparticles (green) recorded at phase of 160◦.
From the above experiments it can be concluded that the signal detected of the
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particles is a result of two photon photothermal lensing (TPPL) that occurs in the
particles material. It is two photon process because of the nonlinear z-confinement
of the signal(see Figure(6.14)) and it is photothermal lensing because it poses similar
properties to TPPL technique reported in previous studies. This conclusion is supported
by evidence from the literature showing that iron oxide nanparticles have an absorption
band at the green spectrum [121, 122]. The broad absorption range covers the 532 nm
which is equivalent to doubling the energy of the 1064 nm beam. So, two 1064 nm are
absorbed nonlinearly benefiting from the high peak intensity of the picosecond pulse.
Given that the 1064 nm beam is intensity modulated, this results in the modulated heat
gradient in the focal point that leads to modulated focussing of the 816 nm beam.
6.6 Summary
This chapter investigated the possible 3D imaging techniques of magnetic nanoparti-
cles using a typical coherent Raman scattering (CRS) imaging system. This, however,
was proceeded by preliminary experiments to assess the capability of imaging doped
gadolinium oxide particles in a conventional confocal microscope. It was found that
the particles provide an enhanced signal with a possibility of single particles detection.
Four waves mixing (FWM) was used to image both gadolinium oxide and iron oxide
nanoparticles in biological contexts. The backward of this technique is that, in order to
obtain distinguishable contrast of the particles, the investigator is required to acquire
two set of images in two different imaging sessions to allow changing the excitation
wavelength. Upconversion photoluminescence was used for the first time to image mag-
netic nanoparticles with CRS setup. These particles can be imaged simultaneously in
a distinguishable contrast within biological structures with unconfined signal in the z
direction. The lack of confinement, however, can be considered as an advantage that
177
Chapter 6. Nanoparticle optical imaging
help finding nanoparticles location in the relatively thick tissue. Two photon photother-
mal lensing was used for the first time to images iron oxide nanoparticles in biological
structures. Simultaneous imaging with distinguishable contrast was achieved by a phase
separation technique.
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Chapter 7
Conclusion and future work
This thesis described the development of nanoparticles contrast agents that can be used
in both MRI and CRS to provide multi-scale imaging of biological tissues. The main
motivation for this is the need of multi-modal imaging technique to understand the
mechanism of anti-cancer nano-medicines.
The label-free MRI and CRS imaging of mouse brain were explored. In MRI, an en-
hanced SNR was achieved using a surface coil within a clinical whole body scanner. The
MRI imaging parameters that provide optimal contrast between tumour and healthy
tissue were explored. It was found that a spin-echo sequence with TR/TE (3000/110
ms) is efficient for tumour edge detection of the formalin fixed mouse brains. The tu-
mour volume of 83 brains were measured from the high resolution MR images (0.125
× 0.125 × 0.150 mm3 ) as part of a collaboration study aiming to investigate three
different anti-cancer drugs on tumour volume as therapeutic response. The MR images
were also used to investigate the accuracy of histology tumour volumetry by assuming
MRI as a gold standard and obtaining semi-histology measurement from the same MRI
data. It was found that histology volume measurements suffer from up to 60% error
with an average of 20%. MRI volumetry is suggested as a higher level alternative tool
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that requires less number of animals to achieve significant statistics, which is desirable
from the ethical prospective. To be able to carry out qualitative comparison between
the two different scale modalities ( MRI and CARS ), a mosaic of CARS images was
proposed and a technique was developed to compensate for plane-curvature and produce
uniform intensity CARS mosaic images.
The particle size was controlled either by changing nucleation time for doped Gd2O3
nanoparticles or by varying the starting FeCl solution with a good degree of size
monodispersity. The crystalline structure was investigated using XRD and it was found
that annealing is an important process to achieve efficient PL and UCP of the doped
gadolinium oxide nanoparticles. Regarding the PL properties of the Er doped gadolin-
ium oxide it was demonstrated that the green/red emissions ratio is tuneable via chang-
ing doping percentages. Moreover, the fingerprint feature of PL as a signature for the
doping element was shown. The upconversion photoluminescence spectroscopy of doped
gadolinium oxide was acquired for the first time in a typical CRS system under a pico-
second pulsed laser excitation. It was found that upconversion photoluminescence of
the Er doped Gd2O3 can be generated efficiently even with the excitation wavelength
tuned away from the Yb absorption at 980 nm. For the Tm doped particles the UC
spectrum was recorded in the near infrared range detecting a strong peak at 811 nm.
Potential NLO imaging techniques to image magnetic nanoparticles in biological tis-
sue were explored. Doped gadolinium oxide nanoparticles were imaged using confocal
microscopy and conclusive data showed efficiency of the PL signal to detect single par-
ticles. FWM was used to image both gadolinium oxide and iron oxide nanoparticles.
Although the later provide relatively strong signal, the drawback of FWM is that it
requires changing wave length and two separate imaging acquisitions are necessary to
achieve distinguishable contrast between tissue and particles. Upconversion photolumi-
nescence was used to image Er doped gadolinium oxide particles because they provide
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efficient emission with the laser of 816 nm, unlike the Tm doped particles which only
emit UC when excited with 980 nm beam. The particle signal however was not confined
in the z-axes due to the linear relationship between signal and laser power resulting from
UC saturation effect which was found to be far below the sensitivity of the CRS system.
Although this is considered as a drawback, it is useful for the purpose of this study when
images from the different scale modalities MRI and CRS are compared. The signal of
the particles is generated even if the plane of imaging is above or below the particles
in 20 µm range which helps locating the particles easily within the 500 µm thick brain
slice. Also, it was demonstrated that the decay lifetime of the UC photoluminescence
is much shorter than a typical pixel dwell time of CRS when imaging scattering tissue,
which allows for clear and sharp edges of the particle aggregations in the image with
no blurring effect in the xy-plane towards scan direction. Although the UC and CARS
images were acquired in two different imaging sessions due to limited financial resources,
it was demonstrated that, in principle, a simultaneous distinguishable contrast image
of starch and particles is possible. TPPL was utilised to image iron oxide nanoparti-
cles with a sharp z-confinment and relatively strong signal when compared to SRS of
starch at the same detection setup. The distinguishable contrast between TPPL of iron
oxide particles and SRS of starch was achieved by changing wavelength of pump beam,
desynchronising pulse trains of the 816 nm and 1064 nm beams, and detecting signal at
different phase. The first two techniques require imaging in different sessions, which is
not desirable specially when imaging nanoparticles in a biological tissue. For the third
technique, it was possible to record simultaneous images of particles by detecting TPPL
at a specific phase, that was determined by conducting a preliminary experiment, and
epi-CARS of starch. The two images were merged in two different colours to show parti-
cles distribution in the biological model. For experiments where the backward direction
is dedicated for another imaging modality the phase and amplitude can be recorded and
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post-image processing can be carried out to obtain the distinguishable contrast.
The main conclusion of this thesis is that MRI can be combined with CRS to image
multi-scale magnetic nanoparticles in biological context. In a label-free manner, MRI
and CRS are capable of distinguishing healthy tissue and tumour as well as registering
the 3D nanoparticles distribution to the tumour microenvironment and the whole body.
Ideally this thesis would have shown the ability of the technique administered to ex-
vivo mouse brain tumours and MRI and CRS combined with other optical techniques
would be utilised to image particles distribution in the biological tissue. However, due to
time and cost limitations this could not be achieved and it is one of the top priorities of
future work. Additionally, the compatibility of the particles to the biological tissue will
be investigated via coating with different surfactants. The impact of these surfactants
and particle size on targeting specific organ or tumour could be examined.
Δz
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Figure 7.1: An xz-projection image of Gd2O3 nanoparticles coated on a glass coverslip
using SRS setup and detecting what might be a stimulated emission.
One of the interesting properties of doped gadolinium oxide nanoparticles that they
provide weak signal in the lock-in amplifier when using SRS setup. This signal is not
due to two-photon photothermal lensing because it vanishes if the two excitation beams
are desynchronised. Moreover, it is surely nonlinear process because it is confined
in the z-direction. Fig.7.1 shows an xz projection of the particles spin coated on a
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glass coverslip confirming the z-confinement . This signal might be due to stimulated
emission that occurs within the possible energy levels of the doped particles when excited
simultaneously with the two excitation beams. Because one of the beam is modulated, a
modulated gain or loss process is detected accordingly. However, further investigations
are required to confirm the origin of this signal and additional optimisation of the
particle doping could be carried out subsequently.
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.1 Image processing
.1.1 3D MRI image normalisation against distance from coil
stacksize = nSlices();
width= getWidth();
length= getHeight();
run(”32-bit”);
setBatchMode(true);
for(k=0;k<stacksize;k++)
{m=0; for(i=0;i<width;i++)
{
for(j=0;j<length;j++){
a=getPixel(i,j);
m=m+a;
}
}
d= width * length;
m=m/d;
run(”Divide...”, ”value=m slice”);
run(”Next Slice [>]”);
}
setBatchMode(false);
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.1.2 Rename images as Tile grid of images
dir1 = getDirectory(”Choose the Directory of your images”);
dir2 = getDirectory(”Choose the Directory where you want to safe the images as Tile ”);
list=getFileList(dir1);
print(list.length);
ymax=25;
xmax=30;
f=-1;
for (y=1; y<=ymax; y++) {
for (x=xmax; x>=1; x–){
f=f+1;
path1 = dir1+list[f];
name=”Tile 001”;
//Zero fill if(y<10)u2=” 00”;
else{ if(y<100) u2=” 0”; else u2=” ”;}
if(x<10)u3=” 00”;
else{ if(x<100) u3=” 0”; else u3=” ”;}
d=name+u2+y+u3+x;
path2 = dir2+d;
open(path1);
saveAs(”Tiff”, path2);
close();
}}
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.2 Tumour volumetry data
Table 1: Tumour volume measured with MRI and semi-histology, Table(1 of 3).
N Image code Tumour Vol-
ume (mm3)
Average radius
(mm)
Semi-histology
volume (mm3)
1 MRI2-48-15 31.50 1.96 31.00
2 MRI2-48-26 21.00 1.65 18.80
3 MRI2-48-31 47.20 1.93 30.00
4 MRI2-48-36 undetectable undetectable undetectable
5 MRI2-48-41 18.70 1.36 10.50
6 MRI2-48-46 27.30 1.42 11.90
7 MRI2-48-51 59.10 2.29 50.10
8 MRI2-48-57 73.70 2.53 68.00
9 MRI2-48-62 undetectable undetectable undetectable
10 MRI2-48-67 103.20 2.93 105.30
11 MRI2-48-72 30.70 1.76 23.00
12 MRI2-48-77 57.80 2.55 69.80
13 MRI2-48-82 59.80 2.37 55.40
14 MRI2-48-87 11.70 1.60 17.30
15 MRI2-48-92 83.40 2.30 50.80
16 MRI2-48-97 36.40 1.93 30.10
17 MRI2-48-102 43.40 1.84 26.00
18 MRI2-48-107 65.40 2.56 70.20
19 MRI2-48-112 undetectable undetectable undetectable
20 MRI2-49-07 undetectable undetectable undetectable
21 MRI2-49-11 undetectable undetectable undetectable
22 MRI2-49-15 89.50 2.13 40.45
23 MRI3-60 50.60 2.26 48.60
24 MRI3-55 72.90 2.44 60.60
25 MRI3-51 30.60 1.83 25.70
26 MRI3-74 98.10 2.87 99.23
27 MRI3-77 11.00 1.38 11.10
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Table 2: Tumour volume measured with MRI and semi-histology, Table(2 of 3).
N Image code Tumour Vol-
ume (mm3)
Average radius
(mm)
Semi-histology
volume (mm3)
28 MRI3-52 93.90 2.72 84.00
29 MRI3-72 63.60 2.38 56.30
30 MRI3-69 37.20 2.01 34.00
31 MRI3-56 43.40 2.07 37.00
32 MRI3-71 undetectable undetectable undetectable
33 MRI3-57 39.90 2.09 38.20
34 MRI3-54 67.70 2.27 49.00
35 MRI3-65 33.60 2.01 34.00
36 MRI3-61 undetectable undetectable undetectable
37 MRI3-63 56.50 2.49 64.83
38 MRI3-80 16.70 1.52 14.78
39 MRI3-70 29.60 2.05 36.10
40 MRI3-83 48.00 2.11 39.10
41 MRI3-62 30.20 1.79 23.90
42 MRI3-81 62.50 2.45 61.40
43 MRI3-66 31.60 2.00 33.50
44 MRI3-64 32.80 2.14 41.20
45 MRI3-67 31.80 1.99 33.00
46 MRI3-76 undetectable undetectable undetectable
47 MRI3-73 78.30 2.60 73.40
48 MRI3-78 129.30 2.61 74.40
49 MRI4-84-C1N5 47.10 1.65 18.72
50 MRI4-84-C5N2 undetectable undetectable undetectable
51 MRI4-85-C2N4 52.80 2.12 39.61
52 MRI4-85-C3N4 undetectable undetectable undetectable
53 MRI4-87-C2N2 25.90 1.75 22.34
54 MRI4-87-C3N3 98.30 2.28 49.30
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Table 3: Tumour volume measured with MRI and semi-histology, Table(3 of 3).
N Image code Tumour Vol-
ume (mm3)
Average radius
(mm)
Semi-histology
volume (mm3)
55 MRI4-88-C1N1 106.00 2.56 70.04
56 MRI4-88-C3N1 99.10 2.74 86.12
57 MRI4-90-C3N5 undetectable undetectable undetectable
58 MRI4-90-C6N4 56.40 2.20 44.43
59 MRI4-91-C2N3 52.60 2.26 48.33
60 MRI4-91-C5N5 undetectable undetectable undetectable
61 MRI4-92-C1N4 15.00 1.64 18.55
62 MRI4-92-C3N2 undetectable undetectable undetectable
63 MRI4-94-C4N2 undetectable undetectable undetectable
64 MRI4-94-C6N5 29.20 1.65 18.81
65 MRI4-95-C1N2 44.20 2.04 35.28
66 MRI4-95-C6N3 39.10 1.93 29.86
67 MRI4-96-C5N4 undetectable undetectable undetectable
68 MRI4-96-C6N2 78.20 2.28 49.30
69 MRI4-97-C5N1 undetectable undetectable undetectable
70 MRI4-97-C6N1 undetectable undetectable undetectable
71 MRI4-98-C1N3 26.70 1.73 21.77
72 MRI4-98-C4N4 42.90 2.37 55.56
73 MRI4-99-C4N1 74.90 2.65 77.91
74 MRI4-100-C4N5 56.20 2.13 40.46
75 MRI4-100-C5N3 undetectable undetectable undetectable
76 MRI4-101-C2N5 30.20 1.93 29.98
77 MRI4-101-C4N3 90.90 2.92 104.24
78 MRI-5-202-C1N1 2.53 0.83 2.37
79 MRI-5-202-C2N2 95.30 2.51 66.20
80 MRI-5-201-C1N3 undetectable undetectable undetectable
81 MRI-5-201-C1N4 2.03 0.77 1.91
82 MRI-5-203-C1N5 1.81 0.86 2.66
83 MRI-5-203-C2N1 43.10 2.04 35.28
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